


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:48:08Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12405487" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12405487</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>ncomms</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Nat Commun</journal-id><journal-id journal-id-type="iso-abbrev">Nat Commun</journal-id><journal-id journal-id-type="pmc-domain-id">2873</journal-id><journal-id journal-id-type="pmc-domain">ncomms</journal-id><journal-title-group><journal-title>Nature Communications</journal-title></journal-title-group><issn pub-type="epub">2041-1723</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12405487</article-id><article-id pub-id-type="pmcid-ver">PMC12405487.1</article-id><article-id pub-id-type="pmcaid">12405487</article-id><article-id pub-id-type="pmcaiid">12405487</article-id><article-id pub-id-type="pmid">40897699</article-id><article-id pub-id-type="doi">10.1038/s41467-025-63479-y</article-id><article-id pub-id-type="publisher-id">63479</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Structural insights into proprotein convertase activation facilitate the engineering of highly specific furin inhibitors</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0009-0009-2247-0648</contrib-id><name name-style="western"><surname>Klaushofer</surname><given-names initials="R">Rupert</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Bloch</surname><given-names initials="K">Konstantin</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0009-0003-4248-4664</contrib-id><name name-style="western"><surname>Eder</surname><given-names initials="LS">Luisa Susanna</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Marzaro</surname><given-names initials="S">Simone</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-0278-4091</contrib-id><name name-style="western"><surname>Schubert</surname><given-names initials="M">Mario</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>B&#246;ttcher-Friebertsh&#228;user</surname><given-names initials="E">Eva</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Brandstetter</surname><given-names initials="H">Hans</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-0915-7579</contrib-id><name name-style="western"><surname>Dahms</surname><given-names initials="SO">Sven O.</given-names></name><address><email>sven.dahms@plus.ac.at</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05gs8cd61</institution-id><institution-id institution-id-type="GRID">grid.7039.d</institution-id><institution-id institution-id-type="ISNI">0000 0001 1015 6330</institution-id><institution>Department of Biosciences and Medical Biology, </institution><institution>University of Salzburg, </institution></institution-wrap>Salzburg, Austria </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05gs8cd61</institution-id><institution-id institution-id-type="GRID">grid.7039.d</institution-id><institution-id institution-id-type="ISNI">0000 0001 1015 6330</institution-id><institution>Center for Tumor Biology and Immunology (CTBI), </institution><institution>University of Salzburg, </institution></institution-wrap>Salzburg, Austria </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01rdrb571</institution-id><institution-id institution-id-type="GRID">grid.10253.35</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9756</institution-id><institution>Institute of Virology, </institution><institution>Philipps University, </institution></institution-wrap>Marburg, Germany </aff></contrib-group><pub-date pub-type="epub"><day>2</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>16</volume><issue-id pub-id-type="pmc-issue-id">478256</issue-id><elocation-id>8206</elocation-id><history><date date-type="received"><day>20</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>14</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 00:25:59.930"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="41467_2025_Article_63479.pdf"/><abstract id="Abs1"><p id="Par1">Proprotein convertases (PCs), including furin and PC1/3 among nine mammalian homologues, mediate the maturation of numerous secreted substrates by proteolytic cleavage. Disbalance of PC activity is associated with diseases like cancer, fibrosis, neurodegeneration and infections. Therefore, PCs are promising drug targets for the treatment of many diseases. However, the highly conserved active site of PCs complicates the development of specific inhibitors.&#160;Here we investigate the activation mechanism of PCs using X-ray crystallography and biochemical methods. The structure-based optimization of the multibasic secondary cleavage site loop not only prevents the prodomain&#8217;s proteolytic cleavage but also increases its inhibition of furin. Combination of cleavage-resistant PC1/3-prodomain variants and a furin-specific nanobody in fusion proteins reveal very potent inhibitors (K<sub>i</sub>&#8201;=&#8201;1.2 pM) with a more than 25,000-fold higher specificity for furin compared to the closely related PC-member PCSK5. Such fusion proteins effectively suppress the replication of a furin-dependent H7N7-influenza virus in cell-based assays.</p></abstract><abstract id="Abs2" abstract-type="web-summary"><p id="Par2">In this work, the authors investigate the activation mechanism of proprotein convertases (PC) based on the PC1/3-prodomain and the PC furin. They engineer a prodomain-nanobody fusion protein that effectively blocks propagation of a H7N7 bird flu virus.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>X-ray crystallography</kwd><kwd>Proteolysis</kwd><kwd>Enzymes</kwd><kwd>Molecular engineering</kwd><kwd>Enzyme mechanisms</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100002428</institution-id><institution>Austrian Science Fund (Fonds zur F&#246;rderung der Wissenschaftlichen Forschung)</institution></institution-wrap></funding-source><award-id>P36648-B</award-id><principal-award-recipient><name name-style="western"><surname>Dahms</surname><given-names>Sven O.</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Nature Limited 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par3">Proprotein convertases (PCs) are Ca<sup>2+</sup>-dependent serine endoproteinases harboring a catalytic domain with structural homology to subtilisin<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. The so called kexin/furin-like mammalian PC family members (furin, PC1/3, PC2, PC4, PACE4, PC5/6 and PC7) recognize multi-basic substrate sequences and cleave after the common pattern (R/K)Xn(R)&#8595; (where <italic toggle="yes">n</italic>&#8201;=&#8201;0, 2, 4, or 6; X represents any amino acid and &#8220;&#8595;&#8221; marks the scissile peptide bond)<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR3">3</xref></sup>. Furin, often regarded as the prototypical PC, is the best-characterized member of this protease family and prefers the consensus cleavage motif R-X-K/R-R&#8595;<sup><xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR5">5</xref></sup>. The zymogens of the furin-like PCs share a multidomain architecture comprising an N-terminal pro-domain, a subtilisin-like catalytic domain, and a P-domain (also called HomoB-domain)<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. These domains are essentially required for maturation of the zymogen and proteolytic activity.</p><p id="Par4">PCs trigger the maturation of a broad range of proteins in the secretory pathway by post-translational proteolytic modification<sup><xref ref-type="bibr" rid="CR1">1</xref>&#8211;<xref ref-type="bibr" rid="CR3">3</xref></sup>. Physiological substrates include the precursors of growth factors, hormones, receptors, matrix metalloproteases, and coagulation factors. Disbalance of PC activity and over- or under-activation of the substrates is associated with many diseases. For instance, unbalanced furin activity promotes cancer-related processes like cell proliferation, metastasis or vascularization<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. Thus, furin is a potential target for cancer therapy<sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR8">8</xref></sup>. In addition to endogenous substrates, PCs processes proteins of many pathogens<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR3">3</xref></sup>. Proprotein convertase inhibitors effectively suppressed the maturation of bacterial toxins<sup><xref ref-type="bibr" rid="CR9">9</xref></sup> and viral envelop proteins, including influenza virus hemagglutinin<sup><xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR11">11</xref></sup> and the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. Consequently, PC-inhibitors are promising therapeutics with a broad range of potential applications. To avoid potential side effects in pharmacological applications, inhibitors should be as specific as possible and preferentially inhibit only the targeted PC-family member<sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR8">8</xref></sup>. The development of selective inhibitors, however, is complicated by the high conservation of the PCs&#8217; active site clefts<sup><xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR14">14</xref></sup>. Targeting less conserved surface patches might be a promising strategy to overcome this limitation. For instance, small molecule inhibitors targeting a cryptic binding pocket of the PCs showed a higher selectivity towards furin than canonical substrate-like inhibitors<sup><xref ref-type="bibr" rid="CR15">15</xref>&#8211;<xref ref-type="bibr" rid="CR17">17</xref></sup>. Inhibitory nanobodies directed against the less conserved P-domain revealed a superior selectivity for furin<sup><xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR19">19</xref></sup>. However, their potency was lower than active site-directed, peptidic, and non-peptidic inhibitors<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>.</p><p id="Par5">The prodomains of the PCs play a central role as intramolecular chaperones and as regulators of the auto-activation mechanisms of these proteases<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. Activation of furin is triggered by two sequential autocatalytic cleavages and subsequent release of the prodomain. The first auto-proteolysis event occurs in the linker region between the prodomain and the catalytic domain directly after folding of the protease in the endoplasmic reticulum<sup><xref ref-type="bibr" rid="CR21">21</xref>,<xref ref-type="bibr" rid="CR22">22</xref></sup>. Trafficking of furin to the late Golgi is accompanied by a drop in pH to 6.0, triggering a second cleavage within the prodomain<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. A pH-sensing function was reported for the PC-prodomains<sup><xref ref-type="bibr" rid="CR24">24</xref></sup> that involves conserved histidine residues<sup><xref ref-type="bibr" rid="CR25">25</xref>&#8211;<xref ref-type="bibr" rid="CR27">27</xref></sup>. A change of the conformation at acidic pH probably results in a higher cleavage susceptibility of the loop that carries the secondary cleavage site (referred to as &#8220;secondary cleavage site loop&#8221;). This mechanism is likely conserved in all furin-like PCs. Although the prodomains of PC4 and PC7<sup><xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR29">29</xref></sup> do not contain a canonical secondary cleavage site, pH-dependent structural changes are thought to play a role for the activation of these proteases.</p><p id="Par6">The PC-prodomains provide an interesting scaffold for inhibitor development. They can be produced in high amounts in bacteria, and potent competitive inhibition of PCs has been demonstrated (up to sub-nM K<sub>i</sub>)<sup><xref ref-type="bibr" rid="CR30">30</xref>,<xref ref-type="bibr" rid="CR31">31</xref></sup>. However, wild-type PC-prodomains come with several major drawbacks: (1) they are rapidly degraded by active PCs due to the auto-activation mechanism, (2) they show a limited specificity and typically inhibit several PC family members, (3) they are less stable in acidic compartments of the secretory system where many substrates are processed by the PCs.</p><p id="Par7">In this work, we investigate the structural and functional basis of PC-activation to engineer prodomain-based PC-inhibitors. Combining stabilized PC1/3-prodomain variants with a furin-specific nanobody, we present a highly furin-specific inhibitory fusion protein with potent activity against influenza A virus.</p></sec><sec id="Sec2" sec-type="results"><title>Results</title><sec id="Sec3"><title>Engineering the PC1/3-prodomain for stable and potent furin inhibition</title><p id="Par8">Due to the secondary cleavage site, the wild-type PC-prodomains are both substrates and inhibitors. This equilibrium is influenced by pH, reflecting the auto-activation process of the PCs. Typically, a shift to lower pH (~6.0) triggers secondary cleavage and thus activation of the PCs. This process can be mimicked mixing the PC1/3-prodomain and furin in a limited proteolysis setup (Fig.&#160;<xref rid="MOESM1" ref-type="media">S1A</xref>). Indeed, we observed degradation of the PC1/3-prodomain, which was increased at pH 6.0 compared to pH 7.4. The PC1/3-prodomain was stable in the absence of furin.</p><p id="Par9">To engineer stable furin inhibitors based on the PC1/3-prodomain, we produced several proteolysis-resistant variants (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>). The secondary cleavage site loop of the PC1/3-prodomain contains the multi-basic motif (77)R-R-S-R-R, including 4 potential cleavage sites: (77)R-R-S-R-R&#8595;, (77)R-R-S-R&#8595;, (77)R-R&#8595; and (80)R-R&#8595;. As reported by Rabah et al., furin cleavage was abolished for the R78A-mutant (<bold>M1</bold>, Fig.&#160;<xref rid="MOESM1" ref-type="media">S1B</xref><sup><xref ref-type="bibr" rid="CR31">31</xref></sup>,). <bold>M1</bold> inhibited furin with a <italic toggle="yes">K</italic><sub>i</sub> of 0.61&#8201;&#177;&#8201;0.02&#8201;nM, which indicates the formation of a stable furin:prodomain-complex (Table&#160;<xref rid="Tab1" ref-type="table">1</xref> and Fig.&#160;<xref rid="MOESM1" ref-type="media">S2A</xref>).<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p><italic toggle="yes">K</italic><sub>i</sub>-values of PC1/3-prodomain secondary cleavage site mutants M1-5 towards furin<inline-graphic id="d33e436" xlink:href="41467_2025_63479_Taba_HTML.gif"/></p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">No.</th><th colspan="1" rowspan="1">77</th><th colspan="1" rowspan="1">78</th><th colspan="1" rowspan="1">80</th><th colspan="1" rowspan="1">81</th><th colspan="1" rowspan="1"><italic toggle="yes">K</italic><sub>i</sub><sup>a</sup> (nM)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">M1</td><td align="left" colspan="1" rowspan="1">R</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">R</td><td align="left" colspan="1" rowspan="1">R</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">0.61&#8201;&#177;&#8201;0.02</td></tr><tr><td align="left" colspan="1" rowspan="1">M2</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">R</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">A</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">0.32&#8201;&#177;&#8201;0.03</td></tr><tr><td align="left" colspan="1" rowspan="1">M3</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">A</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">1.50&#8201;&#177;&#8201;0.02</td></tr><tr><td align="left" colspan="1" rowspan="1">M4</td><td align="left" colspan="1" rowspan="1">R</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">R</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">0.33&#8201;&#177;&#8201;0.03</td></tr><tr><td align="left" colspan="1" rowspan="1">M5</td><td align="left" colspan="1" rowspan="1">R</td><td align="left" colspan="1" rowspan="1">K</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">R</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">0.042&#8201;&#177;&#8201;0.002</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>pH 7.4, 150&#8201;mM NaCl, 37&#8201;&#176;C.</p></table-wrap-foot></table-wrap></p><p id="Par10">The complementary triple mutant (77)A-R-S-A-A (<bold>M2</bold>) was also resistant to proteolysis by furin (Fig.&#160;<xref rid="MOESM1" ref-type="media">S1C</xref>) but revealed more potent inhibition compared to <bold>M1</bold> (<italic toggle="yes">K</italic><sub>i</sub>&#8201;=&#8201;0.32&#8201;&#177;&#8201;0.03&#8201;nM, Table&#160;<xref rid="Tab1" ref-type="table">1</xref> and Fig.&#160;<xref rid="MOESM1" ref-type="media">S2B</xref>). The cleavage-resistant mutant (77)A-A-S-A-A (<bold>M3</bold>) (Fig.&#160;<xref rid="MOESM1" ref-type="media">S1D</xref>) showed weaker inhibition than <bold>M1</bold> (<italic toggle="yes">K</italic><sub>i</sub>&#8201;=&#8201;1.50&#8201;&#177;&#8201;0.02&#8201;nM, Table&#160;<xref rid="Tab1" ref-type="table">1</xref> and Fig.&#160;<xref rid="MOESM1" ref-type="media">S2C</xref>). These results indicate a role of the secondary cleavage site loop for prodomain:protease interactions with a strong contribution of Arg78. Intrigued by this finding, we tested the mutant (77)R-A-S-A-R (<bold>M4</bold>), which revealed a <italic toggle="yes">K</italic><sub>i</sub> of 0.33&#8201;&#177;&#8201;0.03&#8201;nM (Fig.&#160;<xref rid="MOESM1" ref-type="media">S1E</xref>, Table&#160;<xref rid="Tab1" ref-type="table">1</xref>, and Fig.&#160;<xref rid="MOESM1" ref-type="media">S2D</xref>). Apparently, the presence of Arg77 and Arg81 can compensate for the lack of Arg78. Comparing <bold>M1</bold> and <bold>M4</bold>, absence of Arg80 even improved the affinity of the prodomain for furin. We created the mutant (77)R-K-S-A-R (<bold>M5</bold>) that combined these features, carrying positive charges only at positions 77,78, and 81, as well as eliminating all possible multi-basic cleavage motives (Lysine is not recognized by furin at the P4 position). In excellent agreement with the findings above, <bold>M5</bold> (<italic toggle="yes">K</italic><sub>i</sub>&#8201;=&#8201;0.042&#8201;&#177;&#8201;0.002&#8201;nM, Table&#160;<xref rid="Tab1" ref-type="table">1</xref> and Fig.&#160;<xref rid="MOESM1" ref-type="media">S2E</xref>) was ~8-fold more potent than <bold>M2</bold> and ~36-fold more potent than <bold>M3</bold> as well as resistant to auto-activation (Fig.&#160;<xref rid="MOESM1" ref-type="media">S1F</xref>).</p></sec><sec id="Sec4"><title>The secondary cleavage site motif influences the structural stability of the prodomain and its pH-sensor</title><p id="Par11">To test the influence of the secondary cleavage site motif on the overall structural integrity of the PC1/3-prodomain we measured the melting temperatures (<italic toggle="yes">T</italic><sub>m</sub>) using nano-DSF at pH 6.0 (Fig.&#160;<xref rid="MOESM1" ref-type="media">S3A</xref>) and pH 7.4 (Fig.&#160;<xref rid="MOESM1" ref-type="media">S3B</xref>). For the wild-type protein, we measured <italic toggle="yes">T</italic><sub>m</sub>-values of 40.9&#8201;&#177;&#8201;0.1&#8201;&#176;C and 48.2&#8201;&#177;&#8201;0.0&#8201;&#176;C at pH 6.0 and pH 7.4, respectively (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>). This indicates a reduction of the structural stability of the PC1/3-prodomain at pH 6.0. Similar pH-dependent differences of the <italic toggle="yes">T</italic><sub>m</sub>-values were observed for <bold>M2</bold> and <bold>M5</bold> (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>) whereby these mutants showed a slight increase of stability independent of pH. For <bold>M5</bold>, <italic toggle="yes">T</italic><sub>m</sub>-values of 41.2&#8201;&#177;&#8201;0.0&#8201;&#176;C and 48.9&#8201;&#177;&#8201;0.1&#8201;&#176;C were observed at pH 6.0 and pH 7.4, respectively (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>). All Arg78Ala mutants, however, showed a structural destabilization at pH 7.4 but not at pH 6.0. For <bold>M1</bold> we measured <italic toggle="yes">T</italic><sub>m</sub>-values of 41.1&#8201;&#177;&#8201;0.2&#8201;&#176;C and 43.7&#8201;&#177;&#8201;0.0&#8201;&#176;C at pH 6.0 and pH 7.4, respectively. This is a surprising result because a pH-sensing function has been reported only for specific histidine residues of the PC1/3-prodomain so far. In conclusion, the basic residue at position 78 is apparently not only required for the affinity to furin but also to maintain the structural stability of the PC1/3-prodomain. For these reasons, we used the mutants <bold>M2</bold> and <bold>M5</bold> as basis for further experiments.<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>pH-dependent melting temperatures and <italic toggle="yes">K</italic><sub>i</sub>-values of the PC1/3-prodomain mutants M1-10 compared to the wild-type (WT) protein<inline-graphic id="d33e696" xlink:href="41467_2025_63479_Tabb_HTML.gif"/></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" colspan="6"/><th colspan="3" rowspan="1">pH 7.4<sup>a</sup></th><th colspan="3" rowspan="1">pH 6.0<sup>a</sup></th></tr><tr><th rowspan="2" colspan="1"><italic toggle="yes">K</italic><sub>i</sub> (nM)</th><th colspan="2" rowspan="1"><italic toggle="yes">T</italic><sub>m</sub> (&#176;C)</th><th rowspan="2" colspan="1"><italic toggle="yes">K</italic><sub>i</sub> (nM)</th><th colspan="2" rowspan="1"><italic toggle="yes">T</italic><sub>m</sub> (&#176;C)</th></tr><tr><th colspan="2" rowspan="1">Furin<sup>b</sup></th><th colspan="2" rowspan="1">Furin<sup>b</sup></th></tr><tr><th colspan="1" rowspan="1">No.</th><th colspan="1" rowspan="1">72</th><th colspan="1" rowspan="1">77</th><th colspan="1" rowspan="1">78</th><th colspan="1" rowspan="1">80</th><th colspan="1" rowspan="1">81</th><th colspan="1" rowspan="1"/><th colspan="1" rowspan="1">-</th><th colspan="1" rowspan="1">+</th><th colspan="1" rowspan="1"/><th colspan="1" rowspan="1">-</th><th colspan="1" rowspan="1">+</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">WT</td><td align="left" colspan="1" rowspan="1">H</td><td align="left" colspan="1" rowspan="1">R</td><td align="left" colspan="1" rowspan="1">R</td><td align="left" colspan="1" rowspan="1">R</td><td align="left" colspan="1" rowspan="1">R</td><td char="&#xB1;" align="char" colspan="1" rowspan="1"/><td char="&#xB1;" align="char" colspan="1" rowspan="1">48.2&#8201;&#177;&#8201;0.0</td><td char="&#xB1;" align="char" colspan="1" rowspan="1"/><td char="&#xB1;" align="char" colspan="1" rowspan="1"/><td char="&#xB1;" align="char" colspan="1" rowspan="1">40.9&#8201;&#177;&#8201;0.1</td><td char="&#xB1;" align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">M1</td><td align="left" colspan="1" rowspan="1">H</td><td align="left" colspan="1" rowspan="1">R</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">R</td><td align="left" colspan="1" rowspan="1">R</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">0.56&#8201;&#177;&#8201;0.03</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">43.7&#8201;&#177;&#8201;0.0</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">68.8&#8201;&#177;&#8201;0.1</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">2.2&#8201;&#177;&#8201;0.1</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">41.1&#8201;&#177;&#8201;0.2</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">67.0&#8201;&#177;&#8201;0.0</td></tr><tr><td align="left" colspan="1" rowspan="1">M2</td><td align="left" colspan="1" rowspan="1">H</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">R</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">A</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">0.73&#8201;&#177;&#8201;0.02</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">50.1&#8201;&#177;&#8201;0.0</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">71.2&#8201;&#177;&#8201;0.1</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">0.88&#8201;&#177;&#8201;0.03</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">41.9&#8201;&#177;&#8201;0.1</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">68.7&#8201;&#177;&#8201;0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">M3</td><td align="left" colspan="1" rowspan="1">H</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">A</td><td char="&#xB1;" align="char" colspan="1" rowspan="1"/><td char="&#xB1;" align="char" colspan="1" rowspan="1">44.5&#8201;&#177;&#8201;0.0</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">68.5&#8201;&#177;&#8201;0.0</td><td char="&#xB1;" align="char" colspan="1" rowspan="1"/><td char="&#xB1;" align="char" colspan="1" rowspan="1">41.1&#8201;&#177;&#8201;0.0</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">67.8&#8201;&#177;&#8201;0.0</td></tr><tr><td align="left" colspan="1" rowspan="1">M4</td><td align="left" colspan="1" rowspan="1">H</td><td align="left" colspan="1" rowspan="1">R</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">R</td><td char="&#xB1;" align="char" colspan="1" rowspan="1"/><td char="&#xB1;" align="char" colspan="1" rowspan="1">44.7&#8201;&#177;&#8201;0.1</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">69.6&#8201;&#177;&#8201;0.1</td><td char="&#xB1;" align="char" colspan="1" rowspan="1"/><td char="&#xB1;" align="char" colspan="1" rowspan="1">41.0&#8201;&#177;&#8201;0.1</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">67.8&#8201;&#177;&#8201;0.0</td></tr><tr><td align="left" colspan="1" rowspan="1">M5</td><td align="left" colspan="1" rowspan="1">H</td><td align="left" colspan="1" rowspan="1">R</td><td align="left" colspan="1" rowspan="1">K</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">R</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">0.139&#8201;&#177;&#8201;0.008</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">48.9&#8201;&#177;&#8201;0.1</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">75.1&#8201;&#177;&#8201;0.1</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">0.35&#8201;&#177;&#8201;0.02</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">41.2&#8201;&#177;&#8201;0.0</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">70.4&#8201;&#177;&#8201;0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">M6</td><td align="left" colspan="1" rowspan="1">N</td><td align="left" colspan="1" rowspan="1">R</td><td align="left" colspan="1" rowspan="1">R</td><td align="left" colspan="1" rowspan="1">R</td><td align="left" colspan="1" rowspan="1">R</td><td char="&#xB1;" align="char" colspan="1" rowspan="1"/><td char="&#xB1;" align="char" colspan="1" rowspan="1">50.0&#8201;&#177;&#8201;0.0</td><td char="&#xB1;" align="char" colspan="1" rowspan="1"/><td char="&#xB1;" align="char" colspan="1" rowspan="1"/><td char="&#xB1;" align="char" colspan="1" rowspan="1">42.0&#8201;&#177;&#8201;0.1</td><td char="&#xB1;" align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">M7</td><td align="left" colspan="1" rowspan="1">D</td><td align="left" colspan="1" rowspan="1">R</td><td align="left" colspan="1" rowspan="1">R</td><td align="left" colspan="1" rowspan="1">R</td><td align="left" colspan="1" rowspan="1">R</td><td char="&#xB1;" align="char" colspan="1" rowspan="1"/><td char="&#xB1;" align="char" colspan="1" rowspan="1">48.2&#8201;&#177;&#8201;0.1</td><td char="&#xB1;" align="char" colspan="1" rowspan="1"/><td char="&#xB1;" align="char" colspan="1" rowspan="1"/><td char="&#xB1;" align="char" colspan="1" rowspan="1">41.3&#8201;&#177;&#8201;0.0</td><td char="&#xB1;" align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">M8</td><td align="left" colspan="1" rowspan="1">L</td><td align="left" colspan="1" rowspan="1">R</td><td align="left" colspan="1" rowspan="1">R</td><td align="left" colspan="1" rowspan="1">R</td><td align="left" colspan="1" rowspan="1">R</td><td char="&#xB1;" align="char" colspan="1" rowspan="1"/><td char="&#xB1;" align="char" colspan="1" rowspan="1">52.5&#8201;&#177;&#8201;0.2</td><td char="&#xB1;" align="char" colspan="1" rowspan="1"/><td char="&#xB1;" align="char" colspan="1" rowspan="1"/><td char="&#xB1;" align="char" colspan="1" rowspan="1">45.4&#8201;&#177;&#8201;0.1</td><td char="&#xB1;" align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">M9</td><td align="left" colspan="1" rowspan="1">L</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">R</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">A</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">0.62&#8201;&#177;&#8201;0.03</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">54.3&#8201;&#177;&#8201;0.0</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">72.5&#8201;&#177;&#8201;0.0</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">0.35&#8201;&#177;&#8201;0.01</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">47.7&#8201;&#177;&#8201;0.1</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">71.8&#8201;&#177;&#8201;0.0</td></tr><tr><td align="left" colspan="1" rowspan="1">M10</td><td align="left" colspan="1" rowspan="1">L</td><td align="left" colspan="1" rowspan="1">R</td><td align="left" colspan="1" rowspan="1">K</td><td align="left" colspan="1" rowspan="1">A</td><td align="left" colspan="1" rowspan="1">R</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">0.101&#8201;&#177;&#8201;0.007</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">53.0&#8201;&#177;&#8201;0.0</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">75.5&#8201;&#177;&#8201;0.1</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">0.14&#8201;&#177;&#8201;0.01</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">46.3&#8201;&#177;&#8201;0.0</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">73.4&#8201;&#177;&#8201;0.1</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>300&#8201;mM NaCl, 25&#8201;&#176;C.</p><p><sup>b</sup><italic toggle="yes">T</italic><sub>m</sub> of isolated furin: 65.6&#8201;&#177;&#8201;0.0&#8201;&#176;C (pH 7.4) and 63.1&#8201;&#177;&#8201;0.1&#8201;&#176;C (pH 6.0).</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec5"><title>X-ray structures in complex with furin at pH 5.9 and pH 7.0 reveal the pH-sensing mechanism of the PC1/3-prodomain</title><p id="Par12">The pH-dependent destabilization is an unwanted feature of the PC1/3-prodomain for an application as inhibitory protein. To investigate its pH-sensing mechanism, we aimed especially on crystallization of the PC1/3-prodomain:furin complex at the relevant pH. Indeed, we could obtain crystals of <bold>M5</bold>:furin and <bold>M2</bold>:furin at pH 5.9 and pH 7.0, respectively. These crystals were too small to obtain complete datasets of good quality from single crystals. Thus, we applied a micro-crystallography approach for data collection and measured partial datasets from many small crystals that were merged afterwards to obtain a complete dataset. The structures of <bold>M2</bold>:furin and <bold>M5</bold>:furin were refined to 2.0&#8201;&#197; and 2.4&#8201;&#197; resolution (Table&#160;<xref rid="MOESM1" ref-type="media">S1</xref>), respectively. Four and three copies of the PC1/3-prodomain:furin complexes were observed in the asymmetric unit for <bold>M2</bold>:furin and <bold>M5</bold>:furin, respectively.</p><p id="Par13">In both complex structures, the globular part of the prodomain is bound to the western rim of the substrate binding pocket (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref> and Fig.&#160;<xref rid="MOESM1" ref-type="media">S4</xref>). The C-terminal residues 104-110 extend over all non-primed substrate binding pockets of furin (S1-S6). For <bold>M2</bold>:furin and <bold>M5</bold>:furin analysis with PISA revealed average interaction interface areas of 1216&#8201;&#177;&#8201;10&#8201;&#197;<sup>2</sup> and 1228&#8201;&#177;&#8201;7&#8201;&#197;<sup>2</sup>, respectively. This indicates a very similar overall binding topology of the PC1/3-prodomain at both pH values (Fig.&#160;<xref rid="Fig1" ref-type="fig">1B</xref>). This is also reflected by high structural similarities between the <bold>M2</bold>:furin and <bold>M5</bold>:furin complexes, indicated by the average RMSD value of 0.200&#8201;&#177;&#8201;0.013&#8201;&#197;. The globular part of the prodomain (without the C-terminal residues, Arg29-Glu104) of <bold>M2</bold>:furin and of <bold>M5</bold>:furin covers average interaction interface areas of 644&#8201;&#177;&#8201;5&#8201;&#197;<sup>2</sup> and of 675&#8201;&#177;&#8201;10&#8201;&#197;<sup>2</sup>, respectively. This interaction is largely dominated by hydrophobic interactions. The only directed interactions found between the globular part of the prodomain and furin are two hydrogen bonds between the side chain of Ser63 of the prodomain and the carbonyl oxygen of Gly241 of furin, as well as between the side chain of Gln102 of the prodomain and the carbonyl oxygen of Gly241 of furin (Fig.&#160;<xref rid="MOESM1" ref-type="media">S5</xref>). The P1 (Arg110)-, P2 (Lys109)- and P4 (Arg107)-residues of the prodomain&#8217;s extended C-terminus mediate very similar interactions with the substrate binding cleft as reported for substrate-like inhibitors (Fig.&#160;<xref rid="Fig1" ref-type="fig">1A</xref>)<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR32">32</xref></sup>. The amide-nitrogen of the P6-residue (Lys105) forms an additional hydrogen bond with the carbonyl-oxygen of Val231 at the substrate binding cleft of furin (Fig.&#160;<xref rid="MOESM1" ref-type="media">S5</xref>).<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><title>Crystal&#160;structures of the PC1/3-prodomain bound to furin.</title><p>Furin is shown in standard orientation. <bold>A</bold> The molecular surface of furin bound to <bold>M2</bold> (M&#8201;=&#8201;mutant) is colored in yellow (catalytic domain) and brown (P-domain). The prodomain is shown as cartoon representation (cyan). The C-terminal residues 107-110 (P1-P4) are shown as stick model. The secondary cleavage site loop is marked in magenta. Note that this loop of <bold>M2</bold> carries the sequence 77-ARSAA instead of the wild-type sequence 77-RRSRR. <bold>B</bold> Superposition of <bold>M2</bold>:furin (pH 7.0) with <bold>M5</bold>:furin (pH 5.9). The cartoon representations of <bold>M2</bold>:furin and <bold>M5</bold>:furin are colored according to A) and in gray, respectively. The active site residues are given as stick model. The region between His72 and Ala83 was flexible and thus was not built in the model. The positions of this chain break are marked by green circles.</p></caption><graphic id="d33e1172" position="float" orientation="portrait" xlink:href="41467_2025_63479_Fig1_HTML.jpg"/></fig></p><p id="Par14">The main difference between <bold>M2</bold>:furin and <bold>M5</bold>:furin is found for the secondary cleavage site loop between Lys73 and Ala83. This region was well structured in <bold>M2</bold>:furin at pH 7.0, but no electron density was observed in <bold>M5</bold>:furin at pH 5.9. This region was not involved in crystal contacts of the <bold>M2</bold>:furin complex. We also applied crystalline material of the <bold>M5</bold>:furin complex on a gel, showing that the prodomain was intact (Fig.&#160;<xref rid="MOESM1" ref-type="media">S6</xref>). Apparently, the secondary cleavage site loop adopts a specific conformation at pH 7.0 but gets unstructured at pH 5.9. At pH 7.0 the peptide bonds between Ala77 and Ala80 (Arg77 and Arg80 of the wild-type) were found in a beta-strand-like conformation Fig.&#160;<xref rid="Fig2" ref-type="fig">2A</xref>). The carbonyl oxygen and amide nitrogen of Ser79 mediate hydrogen bonds with the amide nitrogen and carbonyl oxygen of Phe31, respectively. To verify the conformation of the secondary cleavage site loop, we solved the structure of isolated <bold>M2</bold> at pH 8.3 and refined it to 1.3&#8201;&#197; resolution (Table&#160;<xref rid="MOESM1" ref-type="media">S1</xref>). Indeed, this region showed the same conformation in isolated and furin-bound <bold>M2</bold> (Figs.&#160;<xref rid="Fig2" ref-type="fig">2B</xref> and S<xref rid="MOESM1" ref-type="media">7A, B</xref>).<fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><title>Secondary cleavage site loop of the PC1/3-prodomain.</title><p><bold>A</bold> Interactions of the secondary cleavage site loop (magenta) of <bold>M2</bold> (M&#8201;=&#8201; mutant) bound to furin. The protein is shown in stick representation, and hydrogen bonds are highlighted by black dashes. <bold>B</bold> Structural alignment of the secondary cleavage site loop (magenta) and flanking regions of isolated <bold>M2</bold> (colored) and of <bold>M2</bold> (gray) bound to furin. For the structure of isolated <bold>M2</bold> only the positions of C<sub>&#945;</sub>, C<sub>&#946;</sub>, and C<sub>&#611;</sub> of the side chain of Arg78 were build. Gln30 was modeled in two conformations. Hydrogen bonds between the side chain of His72 and the backbone nitrogens of Asn74 and His75 are highlighted with black dashes. <bold>C</bold> Stereo view of the secondary cleavage site loop (magenta) and flanking regions of isolated <bold>M2</bold>. Nuclear Overhauser effects (NOEs) measured by NMR spectroscopy (Table&#160;<xref rid="MOESM1" ref-type="media">S2</xref>) are highlighted by yellow dashes. The NOE data suggest flipping of the His75 imidazole ring in solution.</p></caption><graphic id="d33e1257" position="float" orientation="portrait" xlink:href="41467_2025_63479_Fig2_HTML.jpg"/></fig></p><p id="Par15">In conclusion, the binding of the PC1/3-prodomain to furin is mediated by exosite (globular part) as well as substrate-like interactions (C-terminus). The structural data suggest a specific destabilization of the secondary cleavage site loop at acidic pH.</p><p id="Par16"><bold>M2</bold> includes three Arg-Ala mutations to prepare a stable prodomain:furin complex. To confirm structural similarity between <bold>M2</bold> and the wild-type PC1/3-prodomain, we performed NMR-experiments in solution at pH 7.4. For an NMR analysis of the PC1/3-prodomain in solution, uniform <sup>15</sup>N and <sup>13</sup>C/<sup>15</sup>N labeling of the recombinant proteins was applied, and triple-resonance 2D and 3D spectra were used to obtain a complete sequence-specific resonance assignment as a basis for structural studies (Fig.&#160;<xref rid="MOESM1" ref-type="media">S8</xref>). The protein is under this condition folded, and the predicted secondary structure based on the chemical shift assignment agrees with the secondary structure in the crystal structure (Fig.&#160;<xref rid="MOESM1" ref-type="media">S9A</xref>). Whereas the crystal structure reported a &#946;-strand around residues 75-80, the NMR data of that region did not reach the threshold to predict a &#946;-strand (Fig.&#160;<xref rid="MOESM1" ref-type="media">S9A</xref>). It could only hint to some population of a &#946;-strand in that region. We measured <sup>15</sup>N{<sup>1</sup>H} heteronuclear NOE data, a sensitive indicator for dynamics in the sub-nanosecond timescale (Fig.&#160;<xref rid="MOESM1" ref-type="media">S9B</xref>). Surprisingly, residues 75&#8211;80 seem rather rigid (at least in the sub-nanosecond timescale), but Asn74 and His75 show some dynamics.</p><p id="Par17">Unambiguous NOEs within the critical loop region were extracted from the acquired 2D and 3D NOESY spectra (Figs.&#160;<xref rid="Fig2" ref-type="fig">2C</xref> and <xref rid="MOESM1" ref-type="media">S10</xref>, and Table&#160;<xref rid="MOESM1" ref-type="media">S2</xref>). The measured NOEs of residues His75, Arg77 (Ala77 in <bold>M2</bold>), Ser79, Arg80 (Ala80 in <bold>M2</bold>) and Ser72 agree with the X-ray structure. For instance, we found NOE contacts between the amide protons of Ser79 and Phe31, which is in excellent agreement with the interaction of these residues found in the X-ray structure.</p></sec><sec id="Sec6"><title>His72 forms a pH-sensitive hydrogen bond to backbone amide atoms</title><p id="Par18">In the isolated structure of <bold>M2</bold> and in the complex structure with furin, we found an unusual interaction of the His72 side chain with the amide nitrogen atoms of Asn74 and His75 (Figs.&#160;<xref rid="Fig2" ref-type="fig">2B</xref> and <xref rid="MOESM1" ref-type="media">S7B</xref>). The donor-hydrogen-acceptor angle towards Asn74 (169&#176;) indicates a stronger contribution than the less optimal angle towards His72 (155&#176;) as determined from the isolated <bold>M2</bold> structure. The distances between the amide nitrogen atoms and N<sub>&#948;</sub> of His72 are in both cases 3.1&#176;&#197;. This observation is supported by the NMR-data, showing NOEs between His72-H&#949;1 and Asn74-H<sup>N</sup>, H&#946;2, H&#946;3, as well as His72-H&#949;1 and His75 H<sup>N</sup> (Fig.&#160;<xref rid="Fig2" ref-type="fig">2C</xref> and Table&#160;<xref rid="MOESM1" ref-type="media">S2</xref>). A 2D <sup>15</sup>N-HMBC experiment revealed the most common neutral N&#949;2H tautomeric state for His72, His75, and H75 (Fig.&#160;<xref rid="MOESM1" ref-type="media">S11</xref>). His72 can only act as a hydrogen bond acceptor in a deprotonated state. Thus, protonation of His72 at pH 6.0 will change a productive interaction to an unfavored contact, probably destabilizing the conformation of the secondary cleavage site loop. Consistent with this observation, the last amino acid with visible electron density at the N-terminal end of the secondary cleavage site loop in <bold>M5</bold>:furin was His72 (Fig.&#160;<xref rid="MOESM1" ref-type="media">S4B</xref>).</p><p id="Par19">Based on these findings, we conclude that the protonation of His72 would prevent its sidechain-mainchain interactions and destabilize the conformation of the secondary cleavage site loop.</p><p id="Par20">To investigate the pK<sub>a</sub>-values of the histidine residues close to the secondary cleavage site loop of the isolated PC1/3-prodomain, we measured 2D <sup>15</sup>N-HMBC spectra of <sup>15</sup>N-labeled wild-type protein in dependence of the pH. Because of the inherent instability and partial unfolding of the protein at room temperature below pH 7.4 (see above), pH-dependent experiments were performed at ~5&#8201;&#176;C (Fig.&#160;<xref rid="MOESM1" ref-type="media">S12A</xref>). Even under optimized conditions, we observed unfolding of the protein at pH 6.0; thus, the pH range from 6.3 to 7.4 was evaluated further. We followed the chemical shifts of the non-protonated nitrogens (N&#948;1 in case of the H&#949;2H tautomer), because they show the most dramatic chemical shift deviations upon protonation, and they report protonation directly and in a predictable manner (&gt;240&#8201;ppm if unprotonated and ~180 ppm if positively charged). A fit of the data under the assumption that at pH 2.0 all histidine residues are protonated and that the <sup>15</sup>N chemical shift will be then 176 ppm revealed pK<sub>a</sub>-values of 4.82, 5.03, and 5.60 for His72, His75, and His85, respectively (Fig.&#160;<xref rid="MOESM1" ref-type="media">S12B</xref>)<sup><xref ref-type="bibr" rid="CR33">33</xref>,<xref ref-type="bibr" rid="CR34">34</xref></sup>.</p></sec><sec id="Sec7"><title>Engineering of a stable inhibitor:enzyme complex by exchange of His72</title><p id="Par21">According to the observed interaction scheme, we hypothesized that an introduction of an asparagine should be able to substitute His72. However, unlike histidine, asparagine is not protonated and can also act as hydrogen acceptor at pH 6.0. Thus, we expected a stabilization of the secondary cleavage site loop for a His72Asn mutant at pH 6.0. Aspartate also acts as hydrogen acceptor at pH 6.0 and pH 7.4 and should be a suitable substitute for His72 as well. To test this hypothesis, we performed limited proteolysis with the His72Asn (<bold>M6</bold>) and His72Asp (<bold>M7</bold>) mutants of the PC1/3-prodomain. Indeed, we observed reduced cleavage of <bold>M6</bold> and <bold>M7</bold> by furin at pH 6.0 in limited proteolysis experiments compared to the wild-type (Fig.&#160;<xref rid="MOESM1" ref-type="media">S13A&#8211;C</xref>). The secondary cleavage of <bold>M6</bold> and <bold>M7</bold> by furin at pH 7.4 was not affected. This finding supports a crucial role of the histidine-backbone amide interactions as pH-responsive element in the PC1/3-prodomain. The His72Asp mutation also introduces a negative charge, which apparently did not influence cleavage of the secondary cleavage site loop compared to the uncharged His72Asn mutation. In the literature, a His72Leu mutation has been reported to increase the stability of the PC1/3-prodomain and abolish auto-activation of PC1/3 at pH 6.0<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. Based on our structures, we hypothesized, however, that a leucine cannot maintain the same side chain interactions as a histidine at this position and probably causes additional structural effects. Due to its different stereochemical properties, a leucine residue should not fit easily at this position. To test this hypothesis in biochemical assays, we generated a His72Leu mutant of the PC1/3-prodomain (<bold>M8</bold>). For <bold>M8</bold> we indeed observed a largely reduced cleavage by furin at pH 7.4 compared to the wild-type protein (Fig.&#160;<xref rid="MOESM1" ref-type="media">S13D</xref>). At pH 6.0, <bold>M8</bold> was cleaved with comparable efficiency as found for pH 7.4. This result shows that the His72Leu mutation interferes with secondary cleavage of the prodomain in two different ways: (a) by reducing the cleavage rate in general (b) by impairing its pH-sensitivity. In fact, processing of the secondary cleavage site of <bold>M8</bold> by furin was even lower at pH 6.0 compared to the wild-type prodomain at pH 7.4 (Fig.&#160;<xref rid="MOESM1" ref-type="media">S13A, D</xref>).</p><p id="Par22">We also investigated the influence of these mutations on the structural stability of the mutants <bold>M6</bold>, <bold>M7</bold>, and <bold>M8</bold> in nano-DSF experiments. Surprisingly, we observed a drop of the <italic toggle="yes">T</italic><sub>m</sub> of the mutants at pH 6.0 compared to pH 7.4, similar to the wild-type protein (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>). Hereby, <bold>M8</bold> also showed an increased <italic toggle="yes">T</italic><sub>m</sub> at pH 6.0 and pH 7.4 compared to the other mutants. An important difference between these nano-DSF measurements and the limited proteolysis assays is, however, the presence of furin. Thus, we repeated the nano-DSF experiments with the preformed furin:prodomain complexes (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>). To prevent degradation of the prodomain by furin, we introduced the His72Leu mutation in the secondary cleavage site mutants <bold>M2</bold> and <bold>M5</bold>, resulting in the combination mutants <bold>M9</bold> and <bold>M10</bold>. Because nano-DSF measurements rely on tryptophan fluorescence, the signal from furin (11 Trp-residues) is largely dominant over the PC1/3-prodomain (2 Trp-residues). For all complexes, we observed melting curves with one transition point only (Fig.&#160;<xref rid="MOESM1" ref-type="media">S3C, D</xref>). It is noteworthy that the <italic toggle="yes">T</italic><sub>m</sub> of isolated furin was also reduced from 65.6&#8201;&#177;&#8201;0.1&#8201;&#176;C at pH 7.4 to 63.1&#8201;&#177;&#8201;0.0&#8201;&#176;C at pH 6.0. The binding of the prodomains always increased the structural stability of furin, as indicated by increased <italic toggle="yes">T</italic><sub>m</sub>-values at pH-values 6.0 and 7.4. In general, the pH-dependent differences of the <italic toggle="yes">T</italic><sub>m</sub>-values measured for prodomain:furin complexes were smaller compared to the isolated prodomains. The His72Leu combination mutants revealed the highest temperature stabilities with <italic toggle="yes">T</italic><sub>m</sub>-values of 72.5&#8201;&#177;&#8201;0.0&#8201;&#176;C at pH 7.4 and 71.8&#8201;&#177;&#8201;0.0&#8201;&#176;C at pH 6.0 for <bold>M9</bold> and 75.5&#8201;&#177;&#8201;0.1&#8201;&#176;C at pH 7.4 and 73.4&#8201;&#177;&#8201;0.1&#8201;&#176;C at pH 6.0 for <bold>M10</bold>.</p></sec><sec id="Sec8"><title>Combination of secondary cleavage site and H72 mutations inverted the pH-dependent affinity profile of the PC1/3-prodomain</title><p id="Par23">Our findings strongly suggest a dependency between the structure of the secondary cleavage site loop of the PC1/3-prodomain and its inhibitory potency. Thus, we also aimed at the determination of <italic toggle="yes">K</italic><sub>i</sub>-values at pH 6.0. At pH 6.0 and 37&#8201;&#176;C, however, we could not fit the kinetic data with a competitive inhibition model. This could be explained by a partial unfolding of the isolated prodomain under these conditions, as indicated by the relatively low <italic toggle="yes">T</italic><sub>m</sub>-values. To stabilize the PC1/3-prodomain we used optimized assay conditions with 300&#8201;mM NaCl and measured at 25&#8201;&#176;C. For <bold>M5</bold> we observed a ~2.5-fold decreased affinity at pH 6.0 (<italic toggle="yes">K</italic><sub>i</sub>&#8201;=&#8201;0.35&#8201;&#177;&#8201;0.02&#8201;nM) compared to pH 7.4 (<italic toggle="yes">K</italic><sub>i</sub>&#8201;=&#8201;0.139&#8201;&#177;&#8201;0.008&#8201;nM, (Table&#160;<xref rid="Tab2" ref-type="table">2</xref> and Fig.&#160;<xref rid="MOESM1" ref-type="media">S14</xref>). The pH-dependent drop of affinity of <bold>M10</bold> (equivalent to <bold>M5</bold> with His72Leu mutation) was largely reduced, as indicated by <italic toggle="yes">K</italic><sub>i</sub>-values of 0.14&#8201;&#177;&#8201;0.01&#8201;nM and 0.101&#8201;&#177;&#8201;0.007&#8201;nM at pH 6.0 and pH 7.4, respectively. Interestingly, for <bold>M2</bold> we observed similar <italic toggle="yes">K</italic><sub>i</sub>-values at pH 6.0 and pH 7.4 (0.88&#8201;&#177;&#8201;0.03&#8201;nM and 0.73&#8201;&#177;&#8201;0.02&#8201;nM, respectively). Surprisingly, the affinity of the combination mutant <bold>M9</bold> (equivalent to <bold>M2</bold> with His72Leu mutation) was even higher at pH 6.0 (<italic toggle="yes">K</italic><sub>i</sub>&#8201;=&#8201;0.35&#8201;&#177;&#8201;0.01&#8201;nM) compared to pH 7.4 (<italic toggle="yes">K</italic><sub>i</sub>&#8201;=&#8201;0.62&#8201;&#177;&#8201;0.03&#8201;nM).</p></sec><sec id="Sec9"><title>Engineering of a highly furin-specific prodomain-based inhibitor</title><p id="Par24">Nanobodies inhibit furin with excellent specificity but with lower affinity compared to the PC1/3-prodomain. Comparing the structures of furin in complex with <bold>M2</bold> and of furin in complex with the nanobody Nb14<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>, simultaneous binding of both proteins should be possible (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>). Thus, we hypothesized that a fusion protein of the nanobody Nb14 and of the PC1/3-prodomain should result in an improved inhibitor with very high affinity and specificity. According to the structures, the N-terminus of the prodomain is only 27&#8201;&#197; away from the C-terminus of the nanobody. In principle, 8 amino acids are sufficient to bridge this distance and link the two proteins. We tested different linker lengths by energy minimization in COOT. Finally, 11 amino acids were the minimal length to achieve good geometric properties. The linker sequence was chosen to avoid charged amino acids that are prone to degradation by various proteases. On the other hand, amino acid residues were chosen to fit the surface characteristics of the nanobody and of the PC1/3-prodomain at the respective positions. This feature might allow interactions of the linker with the proteins, which might reduce its flexibility and thus its accessibility for proteolytic attack. Using Alphafold3 we predicted the structure of the complex between the nanobody fusion protein of <bold>M9</bold> and furin (referred to as <bold>F1</bold>, Figs.&#160;<xref rid="Fig3" ref-type="fig">3</xref> and S<xref rid="MOESM1" ref-type="media">15</xref>). In this structure, the linker shows the optimal length to connect the fusion partners and maintaining their binding mode. In addition, we also created a fusion protein of <bold>M5</bold> and furin (referred to as <bold>F2</bold>).<fig id="Fig3" position="float" orientation="portrait"><label>Fig. 3</label><caption><title>Structure-based engineering of fusion proteins of the PC1/3-prodomain with the furin-inhibiting nanobody Nb14.</title><p>Superposition of the structures of furin (gray) in complex with <bold>M2</bold> (M&#8201;=&#8201; mutant, blue, experimental structure, this work), Nb14 (yellow, experimental structure, 5JMO<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>) or <bold>F1</bold> (F&#8201;=&#8201;fusion protein, green, predicted by Alphafold 3<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>). The N- and C-termini of the PC1/3-prodomain, as well as the C-terminus of the nanobody, are highlighted. The linker that connects these termini in the fusion protein is colored in orange.</p></caption><graphic id="d33e1611" position="float" orientation="portrait" xlink:href="41467_2025_63479_Fig3_HTML.jpg"/></fig></p><p id="Par25">A competitive inhibition mechanism of <bold>F2</bold> was indicated by a linear relationship of IC<sub>50</sub>-values in dependence on substrate concentration/<italic toggle="yes">K</italic><sub>m</sub>-value under tight binding conditions (Fig.&#160;<xref rid="MOESM1" ref-type="media">S16A</xref>). The <italic toggle="yes">K</italic><sub>i</sub>-values of <bold>F1</bold> and <bold>F2</bold> (150&#8201;mM NaCl, pH 7.4, 37&#8201;&#176;C) were 1.6&#8201;&#177;&#8201;0.4 pM and 1.3&#8201;&#177;&#8201;0.3 pM, respectively (Table&#160;<xref rid="Tab3" ref-type="table">3</xref> and Fig.&#160;<xref rid="MOESM1" ref-type="media">S16B, C</xref>). To test whether the binding mode indeed involves cooperative binding of the nanobody and prodomain parts of the fusion protein, we examined binding to furin<sup>Thr562Arg</sup>. Thr562 is a non-conserved residue within the PC protease family, and its mutation to Arg reduced the affinity of furin to the nanobody but fully maintained the catalytic activity<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. Indeed, the affinity of <bold>F1</bold> and <bold>F2</bold> for furin<sup>Thr562Arg</sup> compared to wild-type furin dropped by more than two orders of magnitude as indicated by the <italic toggle="yes">K</italic><sub>i</sub>-values of 880&#8201;&#177;&#8201;60 pM and 215&#8201;&#177;&#8201;16 pM, respectively (Table&#160;<xref rid="Tab3" ref-type="table">3</xref> and Fig.&#160;<xref rid="MOESM1" ref-type="media">S16D</xref>). This finding and the competitive inhibition mechanism support simultaneous binding of both fusion partners.<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p><italic toggle="yes">K</italic><sub>i</sub>-values of nanobody-PC1/3-prodomain fusion proteins F1 and F2<inline-graphic id="d33e1679" xlink:href="41467_2025_63479_Tabc_HTML.gif"/></p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1"/><th colspan="1" rowspan="1">No.</th><th colspan="1" rowspan="1">Furin</th><th colspan="1" rowspan="1">Furin<sup>T562R</sup></th><th colspan="1" rowspan="1">PC7</th><th colspan="1" rowspan="1">PC5/6</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1"><italic toggle="yes">K</italic><sub>i</sub><sup>a</sup>(pM)</td><td align="left" colspan="1" rowspan="1">F1</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">1.6&#8201;&#177;&#8201;0.4</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">880&#8201;&#177;&#8201;60</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">440&#8201;&#177;&#8201;43</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">36,800&#8201;&#177;&#8201;2700</td></tr><tr><td colspan="1" rowspan="1">F2</td><td colspan="1" rowspan="1">1.3&#8201;&#177;&#8201;0.3</td><td colspan="1" rowspan="1">215&#8201;&#177;&#8201;16</td><td colspan="1" rowspan="1">1200&#8201;&#177;&#8201;110</td><td colspan="1" rowspan="1">32,600&#8201;&#177;&#8201;2400</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>pH 7.4, 150&#8201;mM NaCl, 37&#8201;&#176;C.</p></table-wrap-foot></table-wrap></p><p id="Par26">Next, we tested the specificity of the fusion proteins for PC7 and PC5/6, whereby PC7 shows the lowest and PC5/6 shows high sequence homology to furin among the PC-family. We determined <italic toggle="yes">K</italic><sub>i</sub>-values of <bold>F1</bold> (440&#8201;&#177;&#8201;43 pM) and <bold>F2</bold> (1200&#8201;&#177;&#8201;110 pM) for PC7 showing a stronger inhibition of furin by ~275- and ~900-fold (Table&#160;<xref rid="Tab3" ref-type="table">3</xref> and Fig.&#160;<xref rid="MOESM1" ref-type="media">S16E</xref>). PC5/6 was inhibited by <bold>F1</bold> and <bold>F2</bold> with <italic toggle="yes">K</italic><sub>i</sub>-values of 32,600&#8201;&#177;&#8201;2400 pM and 36,800&#8201;&#177;&#8201;2700 pM (Table&#160;<xref rid="Tab3" ref-type="table">3</xref> and Fig.&#160;<xref rid="MOESM1" ref-type="media">S16F</xref>), respectively. This indicates ~23,000- and ~25,000-fold stronger inhibition of furin by <bold>F1</bold> and <bold>F2</bold> compared to PC5/6. In conclusion, our prodomain-nanobody fusion proteins are highly specific furin inhibitors.</p></sec><sec id="Sec10"><title>Anti-viral activity of prodomain-nanobody fusion proteins</title><p id="Par27">To test the biological activity of our fusion proteins, we tested their antiviral activity in cell culture-based assays. For this purpose, we infected A549 human lung cancer cells with the influenza A virus strain H7N7/SC35M and determined the viral titer in the supernatant at 16, 24, 48, and 72&#8201;h post-infection (Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>). One hour after infection we added the prodomain mutants, the fusion proteins or the nanobody as control protein to the medium. As additional control we also tested a fusion protein of the nanobody and the wild-type PC1/3-prodomain. Untreated cells and cells treated with the previously described furin inhibitor MI-1148<sup><xref ref-type="bibr" rid="CR35">35</xref></sup> served as additional controls. We observed a dose-dependent inhibition of viral replication for fusion protein <bold>F1</bold> with a 10,000-fold reduction in final virus titer at 72&#8201;h post-infection at 10&#8201;&#181;M and a 100-fold reduction at 5&#8201;&#181;M concentration. A slight reduction in virus titer was observed for <bold>F2</bold> at 48&#8201;h post-infection at 10&#8201;&#181;M concentration. In comparison, no antiviral activity was observed for the isolated wild-type PC1/3-prodomain, the isolated mutant prodomains <bold>M5</bold> and <bold>M9</bold> (prodomain parts of <bold>F1</bold> and <bold>F2</bold>), the isolated nanobody, as well as a fusion protein of the nanobody and the wild-type PC1/3-prodomain. MI-1148 completely blocked replication of H7N7/SC35M at a concentration of 1&#8201;&#181;M. We also determined the cleavage of the viral envelope protein hemagglutinin (HA) in the cells by western blot in presence of the prodomain fusion proteins <bold>F1</bold> or <bold>F2</bold> or MI-1148 as a control (Fig.&#160;<xref rid="Fig5" ref-type="fig">5A</xref>). Efficient cleavage of the precursor HA0 into HA1 and HA2 was observed in untreated infected cells. In agreement with the reduction of viral titers by <bold>F1</bold>, cleavage of HA0 into HA1 and HA2 was reduced in a dose-dependent manner and fully prevented in the presence of 10&#8201;&#181;M <bold>F1</bold>, indicating a strong inhibition of PC-dependent HA cleavage. HA0 cleavage was also slightly reduced in <bold>F2</bold> (10&#8201;&#181;M) treated cells compared to untreated cells. In the presence of MI-1148, HA cleavage was blocked, and only the precursor HA0 was detected.<fig id="Fig4" position="float" orientation="portrait"><label>Fig. 4</label><caption><title>Inhibition of multicycle replication of influenza A virus H7N7/SC35M in inhibitor-treated A549 human lung cells.</title><p>Cells were inoculated with virus at an MOI of 0.0001 for 1&#8201;h, washed, and incubated in the presence of 10, 5, or 1&#8201;&#181;M of the indicated inhibitors for 72&#8201;h. As a control, cells were infected with H7N7/SC35M in absence of an inhibitor. At 16, 24, 48, and 72&#8201;h post-infection (p.i.), cell supernatants were collected and viral titers were analyzed by plaque assay. Data are mean values&#8201;+&#8201;SD of three independent experiments (<italic toggle="yes">n</italic>&#8201;=&#8201;3).</p></caption><graphic id="d33e1838" position="float" orientation="portrait" xlink:href="41467_2025_63479_Fig4_HTML.jpg"/></fig><fig id="Fig5" position="float" orientation="portrait"><label>Fig. 5</label><caption><title>Inhibition of proteolytic activation of influenza A virus H7N7/SC35M and stability of the PC1/3-prodomain in cell culture.</title><p><bold>A</bold> Analysis of HA cleavage. A549 cells were infected with H7N7/SC35M at a MOI of 0.1. After a 1&#8201;h incubation, the inoculum was removed and cells were further incubated in the presence of inhibitors for 24&#8201;h. Cell lysates were subjected to SDS-PAGE and Western blot analysis. The precursor HA0 and mature cleavage products HA1 and HA2 were immunochemically detected with an H7 hemagglutinin-specific antibody. Tubulin was used as a loading control. The Western blot shown is representative of three independent experiments (<italic toggle="yes">n</italic>&#8201;=&#8201;3). (M&#8201;=&#8201;mutant, F&#8201;=&#8201;fusion protein) (<bold>B</bold>) Stability of the wild-type PC1/3-prodomain (WT), PC1/3-prodomain mutants (M), and fusion proteins (F) in A549 lung cancer cell cultures. The inhibition is given in % as the ratio between the activity measured with conditioned medium supplemented with the test proteins and cell culture medium. Conditioned medium supplemented with buffer only served as a negative control (Control). The experiment was performed in triplicates (<italic toggle="yes">n</italic>&#8201;=&#8201;3), Mean values and standard deviations are shown; open circles represent individual replicates.</p></caption><graphic id="d33e1858" position="float" orientation="portrait" xlink:href="41467_2025_63479_Fig5_HTML.jpg"/></fig></p><p id="Par28">The different antiviral activities (activity in the cells) of <bold>F1</bold> and <bold>F2</bold> are remarkable because the in vitro inhibitory potency of <bold>F2</bold> was stronger compared to <bold>F1</bold>. This finding suggests that the prodomain part is important for the biological activity of the fusion proteins, i.e., the mutations of the secondary cleavage site and of the pH-sensing His72. To test this hypothesis, we co-incubated the inhibitory proteins in the medium together with A549 human lung cancer cells. Then, we monitored the inhibitory activity of the isolated prodomains and of the prodomain fusion proteins after 24&#8201;h and 72&#8201;h incubation (Fig.&#160;<xref rid="Fig5" ref-type="fig">5B</xref>). For the wild-type prodomain, no inhibitory activity was measured after 24&#8201;h, consistent with processing and inactivation of the prodomain by cellular PCs. In contrast, for <bold>M5</bold> we observed full inhibition at 24&#8201;h and week inhibition until 72&#8201;h. For the combined mutant <bold>M10</bold> (M5 with His72Leu mutation), we observed even after 72&#8201;h ~70% inhibition. Interestingly, the remaining inhibition of <bold>M9</bold> after 72&#8201;h was almost 100%. For the fusion proteins <bold>F1</bold> and <bold>F2</bold> we measured strong inhibition over 72&#8201;h. Nonetheless, we could determine an approx. two-fold lower decline of the inhibition for <bold>F1</bold> in correlation with the findings for <bold>M5</bold> and <bold>M10</bold>. The stable inhibition observed for the fusion proteins indicates that the linker between the prodomain and the nanobody is apparently relatively resistant against proteolytic degradation. This observation is supported by the absence of degradation products in the range of ~15&#8201;kDa in the cell culture supernatants (Fig.&#160;<xref rid="MOESM1" ref-type="media">S17</xref>).</p></sec></sec><sec id="Sec11" sec-type="discussion"><title>Discussion</title><p id="Par29">During the canonical auto-activation of the PCs, the prodomains are autocatalytically cleaved and inactivated in a pH-dependent manner<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. Proteolysis occurs in the secondary cleavage site loop of the prodomains and is initiated&#160;by trafficking of the proteases. After synthesis of the pro-PCs in the endoplasmic reticulum at a pH of 7.4, the lower pH of ~6.0 at the late Golgi triggers the auto-activation process<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. So far, the inherent instability of PC-prodomains has prevented their use as inhibitory proteins. Influenza virus HA is typically cleaved in secretory compartments at pH values of 5.5&#8211;6.0. Under these conditions, the wild-type PC1/3-prodomain could be readily inactivated by endogenous furin, explaining the lack of any antiviral activity.</p><p id="Par30">According to our structural and biochemical data, two main determinants of the pH-sensitivity of the PC1/3-prodomain are (1) the multi-basic motif of the secondary cleavage site loop and (2) His72. In previous studies, Arg&#8594;Ala point mutations at the secondary cleavage site motif either did either not affect or slightly increased its affinity to furin<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>. In fact, we measured an almost identical <italic toggle="yes">K</italic><sub>i</sub> value of <bold>M1</bold> (Arg78Ala) as described in the literature (0.59&#8201;nM<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>). We identified a double (<bold>M5</bold>) and a triple-mutant (<bold>M2</bold>) of the secondary cleavage site motif, maximizing the affinity and the stability of the PC1/3-prodomain.</p><p id="Par31">In the crystal structure of the isolated PC1/3-prodomain and in complex with furin, the side chain imidazole ring of His72 mediates a hydrogen bond to a backbone amide of the secondary cleavage site loop. Protonation of the imidazole ring at acidic pH prevents the hydrogen bond acceptor function of His72 and thus destabilizes the secondary cleavage site loop conformation. This loop is probably more susceptible to proteolytic attack in an unstructured state, explaining the increased furin cleavage of the PC-prodomain at acidic pH. A mutation of His72 to leucine was reported to disrupt the pH-sensing function of the PC1/3-prodomain<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. We could show that this mutation resulted in a global stabilization of the PC1/3-prodomain as indicated by higher melting temperatures at pH 6.0 and pH 7.4. Due to its different stereochemical properties, the leucine side chain might fit better to the hydrophobic core of the prodomain. A combination of the secondary cleavage site triple mutation (77)A-R-S-A-A (<bold>M2</bold>) with the His72Leu mutation resulted in a largely stabilized inhibitory PC1/3-prodomain (<bold>M9</bold>). In fact, the melting temperatures of the furin:<bold>M9</bold> complex at pH 6.0 and pH 7.4 were largely similar. The affinity of <bold>M9</bold> to furin was even higher at pH 6.0 than at pH 7.4.</p><p id="Par32">Interestingly, we observed a relatively low pK<sub>a</sub>-value of 4.82 for His72 of the isolated PC1/3-prodomain. This might be different for the furin-bound prodomain due to the influence of the interaction with the catalytic domain on its biochemical properties.</p><p id="Par33">To achieve both high affinity and selective furin inhibition, we fused our optimized PC1/3-prodomain variants to the C-terminus of a furin-specific nanobody. These fusion proteins indeed revealed very high affinity to furin and very high specificity, especially in comparison to PC5/6. This is a remarkable finding because PC5/6 shows an especially high sequence conservation to furin among the PC-family members<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. In principle, this strategy might be applied to develop highly specific inhibitors against any PC family member. Our optimized PC1/3-prodomain variant <bold>M9</bold> might serve as a general anchoring platform for such fusion proteins. The preformed complex between the prodomain and the PC of interest could be directly used to identify suited nanobodies with display technologies<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>.</p><p id="Par34"><bold>F1</bold> and <bold>F2</bold> showed antiviral activity against the avian influenza virus strain H7N7/SC35M. Hereby, the activity of <bold>F1</bold> was much stronger compared to <bold>F2</bold>, although both fusion proteins showed comparable affinities and specificities. Interestingly, we observed a higher structural stability of <bold>M9</bold> (the prodomain part of <bold>F1</bold>) compared to <bold>M5</bold> (the prodomain part of <bold>F2</bold>) in biochemical assays. Thus, the stability of the prodomain part might be crucial for an antiviral effect of the fusion proteins. This property could be especially important for the half-life of the fusion proteins after cellular uptake. In the secretory compartments, various proteases with broad specificity are present (e.g., the cathepsins)<sup><xref ref-type="bibr" rid="CR38">38</xref>,<xref ref-type="bibr" rid="CR39">39</xref></sup>, which might digest more flexible parts in the fusion proteins (e.g., the linker region or flexible loops). In this context, the pH stability and the increased global structural stability of <bold>M9</bold> (H72L mutation in combination with (77)A-R-S-A-A secondary cleavage site sequence) are probably important. Without these mutations, the pH of ~5.5 as found in endosomes largely destabilizes the PC1/3-prodomain. The prodomain part and especially the secondary cleavage site loop of <bold>F2</bold> (<bold>M5</bold>) might be partially unfolded and thus inactivated through proteolysis by cathepsins and legumain<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>. A more efficient cellular uptake of <bold>F1</bold> compared to <bold>F2</bold> might also contribute to a higher biological activity.</p><p id="Par35">The higher antiviral activity of the peptidic inhibitor MI-1148 compared to <bold>F1</bold> might be explained by different specificities of these inhibitors for different PCs. <bold>F1</bold> inhibits furin ~25,000-fold stronger compared to PC5/6, while MI-1148 showed similar inhibition for both PCs<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. HA of highly pathogenic avian influenza virus (HPAIV) strains, however, is activated by furin and PC5/6<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>. Specific inhibition of furin only cannot result in a complete inhibition of SC35M replication, which is in agreement to the results obtained for <bold>F1</bold>.</p><p id="Par36">Due to their very high affinities, <bold>F1</bold> and <bold>F2</bold> might be applied for sensitive detection of active furin in cells or biological samples. These protein-based inhibitors can be easily fused&#160;to an enzyme (e.g., horse radish peroxidase or luciferase), a fluorescent protein, or an antibody F<sub>c</sub>-domain to facilitate compatibility with common detection approaches.</p></sec><sec id="Sec12"><title>Methods</title><sec id="Sec13"><title>Protein expression and purification</title><p id="Par37">Shortly, Furin<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR42">42</xref></sup>, Furin<sup>T562R</sup>&#8201;<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>, PC5/6<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>, and PC7<sup><xref ref-type="bibr" rid="CR42">42</xref></sup> were expressed in HEK293S cells (ATCC CRL3022, not authenticated) as soluble proteins and purified from conditioned medium. All proteins were initially subjected to immobilized metal affinity purification (IMAC). Furin and Furin<sup>T562R</sup> were further purified by inhibitor-based affinity purification<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>. Finally, the buffer of Furin and Furin<sup>T562R</sup> was exchanged by ultrafiltration (Amicon Ultra 15 Centrifugal Filter Ultracel 30&#8201;K, Merck Millipore) to storage buffer (10&#8201;mM Hepes/NaOH, pH 7.4, 100&#8201;mM NaCl, and 2&#8201;mM CaCl<sub>2</sub>). PC7 was activated in vitro using thermolysin<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>. PC5/6 and PC7 were subjected to a final gel permeation chromatography step (Superdex 200 10/300 GL column, GE Healthcare) coupled to a chromatography system (Aekta Purifier with Unicorn 5.31 software, GE Healthcare) with storage buffer. Details of the cloning procedures, expression, and purification are provided as supplementary information.</p><p id="Par38">Synthesized nucleic acid sequences of the PC1/3 prodomain constructs (wild-type, <bold>M1</bold>-<bold>M5,</bold>
<bold>M9</bold>, and <bold>M10</bold>) and of the nanobody-PC1/3-prodomain fusion constructs were cloned into the pET28a vector (Novagen) by Geneart (Thermo Fisher Scientific). PC1/3 prodomain constructs <bold>M6,</bold>
<bold>M7</bold>, and <bold>M8</bold> (His72 mutants) were generated by site-directed mutagenesis. For protein purification N-terminal His<sub>6</sub>- (used for wild-type, <bold>M2,</bold>
<bold>M3,</bold>
<bold>M9</bold>, and <bold>M10</bold>) or His<sub>6</sub>-mNeongreen- (used for wild-type, <bold>M1,</bold>
<bold>M4</bold>-<bold>M8</bold>) tags were fused to the prodomains via the linker sequence SGTENLYFQG that includes the tobacco etch virus (TEV)-protease cleavage site (ENLYFQ&#8595;G). The expression strategy with the N-terminal His<sub>6</sub>-tag revealed higher protein yields and was applied when higher amounts of protein were needed. After cleavage of the tag, all proteins contained a single N-terminal glycine residue as cloning artifact, followed by the amino acids 28&#8211;110 of human PC1/3 (PCSK1, UNIPROT-ID <ext-link ext-link-type="pmc:entrez-protein" xlink:href="P29120">P29120</ext-link>). We also produced a His<sub>6</sub>-tagged variant of <bold>M5</bold> containing the sequence GHHHHHHSGHM N-terminal to the amino acids 28&#8211;110 of human PC1/3, which was only used for crystallization (see below). Details of the cloning procedures are provided as supplementary information.</p><p id="Par39">The proteins were expressed in <italic toggle="yes">E. coli</italic> BL21 (DE3) grown in lysogeny broth medium (Carl Roth, Karlsruhe, Germany) supplemented with 7.5&#8201;&#181;g&#8201;ml<sup>-1</sup> kanamycin at 37&#8201;&#176;C. At OD<sub>600</sub>&#8201;=&#8201;0.4 the cells were cooled to 26&#8201;&#176;C and protein expression was induced by addition of 1&#8201;mM isopropyl &#946;-d-1-thiogalactopyranoside at OD<sub>600</sub>&#8201;=&#8201;0.8&#8211;1.0. After 4&#8201;h, cells were harvested and stored at &#8722;20&#8201;&#176;C until purification. Cell pellets were resuspended in lysis buffer (100&#8201;mM Tris/HCl, pH 8.0, 500&#8201;mM NaCl), supplemented with 1&#8201;mg&#8201;ml<sup>-1</sup> lysozyme, incubated for 1&#8201;h at 4&#8201;&#176;C, and lysed by sonification. For immobilized metal affinity chromatography (IMAC), the supernatant was supplemented with 10&#8201;mM imidazole and incubated with Ni-NTA Superflow resin (Qiagen, Hilden, Germany) for 30&#8201;min at 4&#8201;&#176;C. The resin was transferred to a gravity flow column and washed 2x with 10 bed volumes of lysis buffer containing 10&#8201;mM imidazole and with 10 bed volumes of lysis buffer containing 20&#8201;mM imidazole. The proteins were eluted with lysis buffer containing 250&#8201;mM imidazole. Prior to cleavage of the tags, the buffer was exchanged to 10&#8201;mM Hepes/NaOH, pH 7.4, 300&#8201;mM NaCl by dialysis (Slide-A-Lyzer, 3.5&#8201;kDa, Thermo&#160;Fisher Scientific). The tags were cleaved by addition of TEV-protease in a ratio of 1:100 (w/w, His<sub>6</sub>-tag) or 1:20 (w/w, His<sub>6</sub>-mNeongreen-tag) and incubation at room temperature overnight. The cleavage reaction was loaded onto Ni-NTA resin. The tag-less target protein was collected in the flow-through as well as after elution with lysis buffer containing 10&#8201;mM imidazole. The PC1/3-prodomain variants were concentrated by ultrafiltration (Amicon Ultra 15 Centrifugal Filter Ultracel 3&#8201;K, Merck Millipore). Final purification was performed by gel filtration chromatography (HiLoad 16/60 Superdex 75&#8201;pg column, Amersham Biosciences) coupled to a chromatography system (Aekta Purifier with Unicorn 5.31 software, GE Healthcare) in 10&#8201;mM Hepes/NaOH, pH 7.4, and 300&#8201;mM NaCl.</p><p id="Par40">For NMR-spectroscopy the N-terminal His<sub>6</sub>- (<sup>15</sup>N-label) or His<sub>6</sub>-mNeongreen-taged (<sup>15</sup>N/<sup>13</sup>C-label) wild-type PC1/3-prodomain was expressed in minimal medium containing 0.5% (w/v) glucose, 50&#8201;mM NH<sub>4</sub>Cl, 2&#8201;mM MgCl<sub>2</sub>, 50&#8201;&#181;M FeCl<sub>3</sub>, 20&#8201;&#181;M CaCl<sub>2</sub>, 10&#8201;&#181;M MnCl<sub>2</sub>, 10&#8201;&#181;M ZnCl<sub>2</sub>, 2&#8201;&#181;M CoCl<sub>2</sub>, 2&#8201;&#181;M CuCl<sub>2</sub>, 2&#8201;&#181;M NiCl<sub>2</sub>, 2&#8201;&#181;M Na<sub>2</sub>MoO<sub>4</sub>, 2&#8201;&#181;M Na<sub>2</sub>SeO<sub>3</sub>, 2&#8201;&#181;M H<sub>3</sub>BO<sub>3</sub>, 25&#8201;mM Na<sub>2</sub>HPO<sub>4</sub>, 25&#8201;mM KH<sub>2</sub>PO<sub>4</sub>, 5&#8201;mM Na<sub>2</sub>SO<sub>4</sub> as described above. For <sup>15</sup>N- and <sup>13</sup>C-labeling, <sup>15</sup>NH<sub>4</sub>Cl (Cambridge Isotope Laboratories) and <sup>13</sup>C<sub>6</sub> glucose (Cambridge Isotope Laboratories) were used, respectively. N-terminal His<sub>6</sub>-tagged PC1/3-prodomain formed non-classical inclusion bodies (IBs) in minimal medium. Cell pellets were resuspended in lysis buffer (100&#8201;mM Tris/HCl, pH 8.0, 500&#8201;mM NaCl), supplemented with 1&#8201;mg&#8201;ml<sup>-1</sup> lysozyme, incubated for 1&#8201;h at 4&#8201;&#176;C, and lysed by sonification. Cell lysates were centrifuged at 17500&#8201;&#215;&#8201;<italic toggle="yes">g</italic>, and the pellet fraction (containing the IBs) was washed in lysis buffer. The IBs were dissolved overnight at 4&#8201;&#176;C in a mixture of 62.5% lysis buffer and 37.5% 50&#8201;mM Tris/HCl, pH 9.0, 8&#8201;M urea. For IMAC the solubilization mixtures were supplemented with 10&#8201;mM imidazole. The isotope labeled protein variants were purified according to the procedure described above, and the buffer was exchanged to 50&#8201;mM Na<sub>2</sub>HPO<sub>4</sub>/NaH<sub>2</sub>PO<sub>4</sub>, 150&#8201;mM NaCl, pH 7.4 by dialysis. The protein concentration was adjusted to 200&#8201;&#181;M, and 7.0% (v/v) D<sub>2</sub>O was added prior to NMR measurements (see below).</p><p id="Par41">The nanobody fusion proteins were expressed with an N-terminal pelB secretion-signal sequence and an His<sub>6</sub>-tag fused to the N-terminus of the nanobody via the linker sequence SGTENLYFQG. The PC1/3-prodomain was fused C-terminal to the nanobody using the linker sequence GQVTSAGASGQ (Table&#160;<xref rid="Tab3" ref-type="table">3</xref>). The fusion proteins were expressed in terrific broth (Carl Roth, Karlsruhe, Germany) supplemented with 7.5&#8201;&#181;g&#8201;ml<sup>-1</sup> kanamycin at 37&#8201;&#176;C. At OD<sub>600</sub>&#8201;=&#8201;~&#8201;1.0 the cells were cooled to 26&#8201;&#176;C, and protein expression was induced by addition of 1&#8201;mM isopropyl &#946;-d-1-thiogalactopyranoside at OD<sub>600</sub>&#8201;=&#8201;10. After overnight incubation, cells were harvested and stored at &#8722;20&#8201;&#176;C until purification. Preparation and solubilization of the non-classical IBs, protein purification, and tag removal were performed as described above.</p><p id="Par42">The nanobody Nb14 was expressed as a reverse fusion construct with the PC1/3-prodomain <bold>M2</bold>. For this purpose, the construct contained the N-terminal pelB secretion signal, a His<sub>6</sub>-tag, the PC1/3-prodomain, and the nanobody at the C-terminus. Between Glu106 PC1/3-prodomain and Gln1 of the nanobody, the linker sequence NLYFQGS was placed, containing the TEV-cleavage site. Expression, purification, and tag removal were performed as described above.</p></sec><sec id="Sec14"><title>Limited proteolysis assays</title><p id="Par43">Proteolysis of PC1/3 prodomain variants at pH 6.0 (50&#8201;mM Mes/NaOH, pH 6.0, 150&#8201;mM NaCl, 2&#8201;mM CaCl2) and pH 7.5 (50&#8201;mM Hepes/NaOH, pH 7.5, 150&#8201;mM NaCl, 2&#8201;mM CaCl2) was investigated by incubation with different concentrations of recombinant furin at 37&#8201;&#176;C. <bold>M1</bold>-<bold>M5</bold> and the wild-type protein (control) were incubated at a concentration of 0.189&#8201;mg&#8201;ml<sup>-1</sup> with furin in a 1.5:1 molar ratio. <bold>M6</bold>-<bold>M8</bold> and the wild-type protein (control) were incubated at a concentration of 0.189&#8201;mg&#8201;ml<sup>-1</sup> with furin in a 15:1 molar ratio. PC1/3-prodomain without furin was used as control. Progress of proteolysis was investigated after distinct time points via SDS-PAGE.</p></sec><sec id="Sec15"><title>Enzyme kinetic assays</title><p id="Par44">Furin inhibition constants of <bold>M1-M5</bold>, <bold>F1</bold>, and <bold>F2</bold> were determined at condition 1 (50&#8201;mM Hepes/NaOH, pH 7.4, 150&#8201;mM NaCl, 2&#8201;mM CaCl<sub>2</sub>, 0.2% (v/v) Triton X-100 at 37&#8201;&#176;C) with Pyr-Glu-Arg-Thr-Lys-Arg-7-amino-4-methylcoumarin (pERTKR-AMC, Bachem) as substrate. pH-dependent inhibition assays of <bold>M1,</bold>
<bold>M2,</bold>
<bold>M5,</bold>
<bold>M9</bold>, and <bold>M10</bold> with furin were performed at condition 2 (50&#8201;mM Mes/NaOH, pH 6.0, 300&#8201;mM NaCl, 2&#8201;mM CaCl<sub>2</sub>, 0.2% (v/v) Triton X-100 at 25&#8201;&#176;C) or at condition 3 (50&#8201;mM Hepes/NaOH, pH 7.4, 300&#8201;mM NaCl, 2&#8201;mM CaCl<sub>2</sub>, 0.2% (v/v) Triton X-100 at 25&#8201;&#176;C) with Ac-RR(Tle)KR-AMC as substrate (substrate 10)<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>. <bold>F1</bold> and <bold>F2</bold> inhibition of furin T562R, PC7, and PC5 was investigated at condition 1 using the substrates pERTKR-AMC, H-RR(Tle)KR-AMC (substrate 11)<sup><xref ref-type="bibr" rid="CR44">44</xref></sup> and pERTKR-AMC, respectively. For each measurement series, <italic toggle="yes">K</italic><sub>m</sub>-values were determined and used for calculation of the <italic toggle="yes">K</italic><sub>i</sub>-values. Concentrations of the enzymes and substrates used for <italic toggle="yes">K</italic><sub>m</sub>- and <italic toggle="yes">K</italic><sub>i</sub>-determinations are summarized in Table&#160;<xref rid="MOESM1" ref-type="media">S3</xref>. The reactions were started by the addition of substrate, and the fluorescence was measured in a microplate reader (Spark with SparkControl v 3.2 or Infinite 200 with i-control 2.0.10.0, Tecan) at excitation and emission wavelengths of 380&#8201;nm and 460&#8201;nm, respectively. All measurement series were performed in triplicates (<italic toggle="yes">n</italic>&#8201;=&#8201;3). The data were evaluated as replicate values in GraphPad Prism (version 10.2.2 GraphPad Software, La Jolla, CA). Enzyme kinetic data were evaluated using the prebuild &#8220;Michaelis-Menten&#8221; model to calculate <italic toggle="yes">K</italic><sub>m</sub> and the Morrison equation for <italic toggle="yes">K</italic><sub>i</sub> determination under tight-binding conditions. The enzyme concentration was fixed for curve fitting using the Morrison equation. For <italic toggle="yes">K</italic><sub>i</sub> determinations of <bold>F1</bold> and <bold>F2</bold> with furin under tight-binding conditions, the enzyme concentrations were fitted, resulting in enzyme concentrations of 83&#8201;&#177;&#8201;7 pM and 97&#8201;&#177;&#8201;7 pM, respectively. The <italic toggle="yes">K</italic><sub>i</sub>-values of non-tight binding, competitive inhibition were evaluated using the model <italic toggle="yes">v</italic>&#8201;=&#8201;V<sub>max</sub>*[<italic toggle="yes">S</italic>]/([<italic toggle="yes">S</italic>]&#8201;+&#8201;<italic toggle="yes">K</italic><sub>m</sub>(1&#8201;+&#8201;[<italic toggle="yes">I</italic>]/<italic toggle="yes">K</italic><sub>i</sub>)) with <italic toggle="yes">v</italic>&#8201;=&#8201;reaction velocity, <italic toggle="yes">V</italic><sub>max</sub>&#8201;=&#8201;maximum velocity, [<italic toggle="yes">S</italic>]&#8201;=&#8201;substrate concentration, <italic toggle="yes">K</italic><sub>m</sub>&#8201;=&#8201;Michaelis-Menten constant, <italic toggle="yes">K</italic><sub>i</sub>&#8201;=&#8201;inhibition constant and [<italic toggle="yes">I</italic>]&#8201;=&#8201;inhibitor concentration. The standard errors of the curve fit are always given for the determined <italic toggle="yes">K</italic><sub>i</sub> and <italic toggle="yes">K</italic><sub>m</sub> values.</p><p id="Par45">The inhibition mode of <bold>F2</bold> was investigated at condition 1 with 50 pM furin. IC<sub>50</sub> values were measured for inhibitor concentration ranges 6.3 pM&#8211;400.6 pM (at 25&#8201;&#181;M and 50&#8201;&#181;M pERTKR-AMC) and 12.5 pM&#8211;801.2 pM (at 100&#8201;&#181;M, 150&#8201;&#181;M, and 200&#8201;&#181;M pERTKR-AMC). For all substrate concentrations measurements without inhibitor were performed as well. All measurements were performed in triplicates. IC<sub>50</sub> values were determined in GraphPad Prism fixing the upper and lower limits to the reaction velocity without inhibitor and 0, respectively.</p></sec><sec id="Sec16"><title>nanoDSF measurements</title><p id="Par46">The melting temperatures (<italic toggle="yes">T</italic><sub>m</sub>) of the isolated PC1/3-prodomain were determined at 50&#8201;mM NaH<sub>2</sub>PO<sub>4</sub>/NaOH, pH 6.0, 300&#8201;mM NaCl and 50&#8201;mM NaH<sub>2</sub>PO<sub>4</sub>/NaOH, pH 7.4, 300&#8201;mM NaCl using a Tycho nanoDSF instrument (NanoTemper, Germany) using ~20&#8201;&#181;M protein. <italic toggle="yes">T</italic><sub>m</sub>-values of PC1/3-prodomain-furin complexes and isolated furin were determined in 50&#8201;mM Mes/NaOH, pH 6.0, 150&#8201;mM NaCl, 2&#8201;mM CaCl<sub>2</sub>, and 50&#8201;mM Hepes/NaOH, pH 7.4, 150&#8201;mM NaCl, 2&#8201;mM CaCl<sub>2</sub> using 3.8&#8201;&#181;M furin and 5.8&#8201;&#181;M prodomain. To ensure saturation of furin with the prodomain, a molar ratio of 1:1.5 (furin:PC1/3pro) was applied. Melting curves were obtained from the ratio between the fluorescence intensities at 330 and 350&#8201;nm. Melting curves were evaluated in GraphPad Prism determining <italic toggle="yes">T</italic><sub>m</sub> from the peak of the first order derivatives. All measurements were performed in triplicates and the errors are given as standard deviations.</p></sec><sec id="Sec17"><title>Protein crystallography</title><p id="Par47">The <bold>M2</bold>:furin complex was prepared mixing 4&#8201;mg/ml furin, 7.1&#8201;mg/ml <bold>M2</bold> and 10&#8201;mM Hepes/NaOH, pH 7.4, 2&#8201;mM CaCl<sub>2</sub> in a ratio (v/v) of 7.5:1:2 to obtain a molar ration of 1.3/1 of <bold>M2</bold>/furin and a final buffer concentration of 10&#8201;mM Hepes/NaOH, pH 7.4, 100&#8201;mM NaCl, 2&#8201;mM CaCl<sub>2</sub>. The protein mixture was concentrated to 15&#8201;mg/ml using an ultrafiltration membrane with 30&#8201;kDa cutoff and initially crystallized in a sitting drop vapor diffusion setup mixing protein solution and 2.8&#8201;M sodium acetate pH 7.0 in a ratio 1:1. The very thin plate-like crystals appeared after 8 months. To reproduce the crystals, the <bold>M2</bold>:furin mixture was concentrated to 27.0&#8201;mg/ml and mixed with 3.75&#8201;M sodium acetate pH 7.0, 10&#8201;mM Hepes/NaOH pH 7.4, 1&#8201;mM CaCl<sub>2</sub> in a ratio 1:1 in sitting drop crystallization setups. The dops were incubated overnight and seeded from the initial crystallization condition. Very small crystals (spacegroup P1, longest dimension of &#8804;20&#8201;&#181;m) were reproduced within several days. For data collection crystals were mounted on a micro-mesh (20&#8201;&#181;m grid size, MiTeGen) draining excessive reservoir solution with a small piece of chromatography paper (Whatman), and flash-cooled in N<sub>2</sub>-l. Diffracting crystals were identified using a mesh scan and measured with the 10&#8201;&#181;M aperture at ID23-1 at the European Synchrotron Radiation Facility (ESRF<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>), using MxCube3 (<ext-link ext-link-type="uri" xlink:href="https://www.mxcube.org">https://www.mxcube.org</ext-link>). The data were processed using XDS<sup><xref ref-type="bibr" rid="CR46">46</xref></sup> (v Jan 10, 2022) with XDS-APP<sup><xref ref-type="bibr" rid="CR47">47</xref></sup> (v 2.9) and programs of the CCP4 program suite<sup><xref ref-type="bibr" rid="CR48">48</xref></sup> (v 7.0.078). 80&#176;-datasets of 19 different crystals were evaluated for data merging using a custom python script<sup><xref ref-type="bibr" rid="CR49">49</xref></sup> (v1). The script iteratively tested all datasets for successive merging with the other datasets in XSCALE<sup><xref ref-type="bibr" rid="CR46">46</xref></sup> (v Jan 10, 2022) to reach the highest possible completeness while obtaining highest possible I/sig- and CC<sub>1/2</sub>-values of the merged datasets. Data merging of the clustering datasets from this analysis was manually optimized (Table&#160;<xref rid="MOESM1" ref-type="media">S1</xref>).</p><p id="Par48">Crystals of isolated <bold>M2</bold> grew in several crystallization conditions of the initial screen of the <bold>M2</bold>:furin complex (see above). Best diffracting crystals grew in 0.2&#8201;M sodium citrate tribasic dihydrate, 20% (w/v) Polyethylene glycol 3,350. Crystals were flash-cooled in N<sub>2</sub>-l and data were collected at ID23-1 (ESRF) using MxCube3 (<ext-link ext-link-type="uri" xlink:href="https://www.mxcube.org">https://www.mxcube.org</ext-link>). Diffraction data were processed using XDS<sup><xref ref-type="bibr" rid="CR46">46</xref></sup> (v Jun 30, 2023) with XDS-APP<sup><xref ref-type="bibr" rid="CR47">47</xref></sup> (v2.9) and programs of the CCP4 program suite<sup><xref ref-type="bibr" rid="CR48">48</xref></sup> (v 7.0.078).</p><p id="Par49"><bold>M5</bold>:furin complex was prepared mixing 3.8&#8201;mg/ml furin, 8.1&#8201;mg/ml His<sub>6</sub>-tagged <bold>M5</bold> in a ratio (v/v) of 8.3:1 to obtain a molar ratio of 1.4/1 of <bold>M5</bold>/furin. Water and&#160;100&#8201;mM CaCl<sub>2</sub>&#160;were added to obtain&#160;a final buffer concentration of 8.2&#8201;mM Hepes/NaOH, pH 7.4, 100&#8201;mM NaCl, 2&#8201;mM CaCl<sub>2</sub>. The protein&#160;solution was concentrated and prepared for crystallization as described for <bold>M2</bold>:furin (see above), obtaining heavily intergrown crystals in 100&#8201;mM sodium citrate, pH 5.9, 0.5&#8201;mM (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, and 1.0&#8201;M LiSO<sub>4</sub>. The crystals were suspended in 100&#8201;mM sodium citrate, pH 5.9, 0.5&#8201;mM (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, 1.38&#8201;M LiSO<sub>4</sub>, and 1&#8201;mM CaCl<sub>2,</sub> vortexed with glass beads (diameter 0.5&#8201;mm) and centrifuged @ 3000&#8201;&#215;&#8201;<italic toggle="yes">g</italic>. Aliquots of the supernatant were frozen in N<sub>2</sub>-l, stored @ &#8722;80&#8201;&#176;C, and used directly after thawing for micro-seeding. Single crystals of <bold>M5</bold>:furin were obtained mixing the protein mixture in a 1:1 ratio with 100&#8201;mM sodium citrate, pH 5.9, 0.5&#8201;mM (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, and 0.8&#8201;M LiSO<sub>4</sub> followed by an overnight incubation and micro-seeding. Needle-shaped micro-crystals (spacegroup P2<sub>1</sub>, smallest dimension &lt;5&#8201;&#181;m, longest dimension &lt;20&#8201;&#181;m) were observed within several days. For cryo-protection a micro-mesh (400&#8201;&#215;&#8201;400&#8201;&#181;m, 10&#8201;&#181;m grid size, MiTeGen) filled with crystals was transferred to 100&#8201;mM sodium citrate, pH 5.9, 0.5&#8201;mM (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub> and 1.38&#8201;M LiSO<sub>4</sub> and 1&#8201;mM CaCl<sub>2</sub> supplemented with 20% (v/v) glycerol, immediately drained on a small piece of chromatography paper (Whatman) and flash-cooled in N<sub>2</sub>-l. Using a mesh-and-collect data collection strategy at the microfocus beamline ID23-2 at the ESRF<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>, we identified diffracting crystals and collected 94 10&#176;- or 20&#176;-datasets. Data collection software was MxCube3 (<ext-link ext-link-type="uri" xlink:href="https://www.mxcube.org">https://www.mxcube.org</ext-link>). The datasets were automatically processed with XDS<sup><xref ref-type="bibr" rid="CR46">46</xref></sup> (v Feb 5, 2021) in combination with XDS-APP<sup><xref ref-type="bibr" rid="CR47">47</xref></sup> (v 2.9) or alternatively by running XDS in a custom TCL script<sup><xref ref-type="bibr" rid="CR49">49</xref></sup> (v1). Using this custom script, refinement of the detector distance and unit cell constants was done in consecutive integration runs, which resulted for many datasets in better data quality. The data of 79 microcrystals were merged using our custom Python script as described above with XSCALE<sup><xref ref-type="bibr" rid="CR46">46</xref></sup> (v Jan 10, 2022; Table&#160;<xref rid="MOESM1" ref-type="media">S1</xref>).</p><p id="Par50">The crystal structure of <bold>M2</bold> was solved by molecular replacement (MR) using the PC1/3-prodomain structure from the AlphaFold Protein Structure Database (<ext-link ext-link-type="uri" xlink:href="https://alphafold.ebi.ac.uk/">https://alphafold.ebi.ac.uk/</ext-link>)<sup><xref ref-type="bibr" rid="CR51">51</xref>,<xref ref-type="bibr" rid="CR52">52</xref></sup> as search model in PHASER<sup><xref ref-type="bibr" rid="CR53">53</xref></sup> (v 2.8.3). In contrast, the NMR-structure of the mouse PC1/3-prodomain (PDB-ID 1KN6)<sup><xref ref-type="bibr" rid="CR54">54</xref></sup> did not reveal a useful MR-solution in our hands, probably because of huge structural differences to the structure of the human PC1/3-prodomain of this study (C&#945;-RMSD&#8201;=&#8201;2.9&#8201;&#197;, Fig.&#160;<xref rid="MOESM1" ref-type="media">S18</xref>). The structures of <bold>M2</bold>:furin and <bold>M5</bold>:furin were solved by molecular replacement (MR) using the PDB-ID 5JXG<sup><xref ref-type="bibr" rid="CR5">5</xref></sup> and the herein determined structure of isolated <bold>M2</bold> (see below) as search models in PHASER<sup><xref ref-type="bibr" rid="CR53">53</xref></sup> (v 2.8.3). COOT<sup><xref ref-type="bibr" rid="CR55">55</xref></sup> (v 0.8.8) was used for model building. Refinement and the calculation of composite omit maps were performed in PHENIX<sup><xref ref-type="bibr" rid="CR56">56</xref></sup> (v 1.20.1). For the refinement of <bold>M5</bold>:furin automatic ncs-group assignment was enabled. Electron density composite omit maps were calculated in PHENIX<sup><xref ref-type="bibr" rid="CR56">56</xref></sup> (v 1.20.1). PYMOL (v 2.0.7) was used for molecular graphics (<ext-link ext-link-type="uri" xlink:href="http://www.pymol.org">http://www.pymol.org</ext-link>) and structural alignments.</p><p id="Par51">For analysis of the protein content in <bold>M5</bold>:furin crystals, 5&#8201;&#181;l microcrystal suspension was harvested from the crystallization screen. The crystals were centrifuged 1&#8201;min at 17000&#8201;&#215;&#8201;<italic toggle="yes">g</italic>, and the mother liquor was removed. The pellet was washed three times by addition of 50&#8201;&#181;l 100&#8201;mM sodium citrate, pH 5.9, 500&#8201;mM (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, 1.38&#8201;M LiSO<sub>4</sub>, and 1&#8201;mM CaCl<sub>2</sub> and centrifugation at 3000&#8201;&#215;&#8201;<italic toggle="yes">g</italic>. 25% of the remaining microcrystal pellet was loaded to SDS-PAGE together with furin (2.5&#8201;&#181;g) and His<sub>6</sub>-tagged <bold>M5</bold> (1&#8201;&#181;g) as controls.</p></sec><sec id="Sec18"><title>NMR spectroscopy</title><p id="Par52">NMR spectra were recorded on a 600&#8201;MHz Avance III-HD spectrometer (Bruker Biospin) equipped with a QXI (<sup>1</sup>H/<sup>13</sup>C/<sup>15</sup>N/<sup>31</sup>P) probe at 298&#8201;K unless stated otherwise. Samples were measured in standard 5&#8201;mm tubes (Armar, TA quality) containing 0.2&#8201;mM protein, 50&#8201;mM NaH<sub>2</sub>PO<sub>4</sub>/Na<sub>2</sub>HPO<sub>4</sub>, 150&#8201;mM, pH 7.4, 7% (v/v) D<sub>2</sub>O, and 93% ddH<sub>2</sub>O. Sequence specific assignment was achieved using 2D <sup>1</sup>H-<sup>15</sup>N HSQC, 2D <sup>1</sup>H-<sup>13</sup>C HSQC, 3D HNCA, 3D CBCA(CO)NH, 3D HNCACB, 3D HNCO, 3D HN(CA)CO, 3D (H)CCH-TOCSY, 3D <sup>15</sup>N-edited NOESY-HSQC, 3D <sup>13</sup>C-edited NOESY-HSQC spectra<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>. For the 3D (H)CCH-TOCSY spectrum a mixing time of 21.7&#8201;ms was used. All NOESY experiments were recorded using a mixing time of 120&#8201;ms unless stated otherwise. A high resolution 2D <sup>1</sup>H-<sup>1</sup>H NOESY with <sup>15</sup>N decoupling and a 2D <sup>1</sup>H-<sup>1</sup>H TOCSY spectrum with <sup>15</sup>N decoupling were recorded using the <sup>15</sup>N sample. Steady state <sup>15</sup>N{<sup>1</sup>H}heteronuclear Overhauser effects were measured according to Farrow et al.<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>. For the assignment of the tautomeric forms of imidazole rings of histidines 2D <sup>1</sup>H-<sup>15</sup>N HMBC spectra were used<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>. Additional experimental details of the applied NMR experiments are provided in Table&#160;<xref rid="MOESM1" ref-type="media">S4</xref>.</p><p id="Par53">For estimating pKa values, we measured 2D <sup>1</sup>H-<sup>15</sup>N HMBC spectra at pH values of 7.4, 6.8, 6.6, 6.3, and 6.0 at 278&#8201;K. Titration of the sample by direct addition of acid was not possible and resulted in precipitation of the protein. Therefore, the protein was re-buffered gently to 50&#8201;mM NaH<sub>2</sub>PO<sub>4</sub>/Na<sub>2</sub>HPO<sub>4</sub>, 150&#8201;mM NaCl with the adjusted pH at 80 &#956;M concentration by dialysis at 4&#8201;&#176;C. Subsequently, the protein was concentrated to 0.2&#8201;mM using ultrafiltration.</p><p id="Par54">Data were processed using Topspin 3.5/3.6 (Bruker Biospin) and analyzed with Sparky 3.114 (T. D. Goddard and D. G. Kneller, SPARKY 3, University of California, San Francisco, USA). Spectra were referenced to 2,2-dimethyl-2-silapentane-5-sulfonic acid (DSS) using an external sample of 2&#8201;mM sucrose and 0.5&#8201;mM DSS in 10% D<sub>2</sub>O/90% H<sub>2</sub>O (Bruker Biospin) for any applied temperature. The chemical shifts of <sup>13</sup>C and <sup>15</sup>N were referenced using the IUPAC-IUB recommended chemical shift referencing ratios &#926; of 0.251449530 (<sup>13</sup>C) and 0.10132918 (<sup>15</sup>N).</p></sec><sec id="Sec19"><title>Alphafold calculations</title><p id="Par55">The structure of <bold>F1</bold> in complex with furin has been predicted using the Alphafold 3 server (<ext-link ext-link-type="uri" xlink:href="https://alphafoldserver.com">https://alphafoldserver.com</ext-link><sup><xref ref-type="bibr" rid="CR60">60</xref></sup>). The input was defined using the structured part of human furin as observed for PDB ID 5JXG<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>, the complete <bold>F1</bold> sequence, three Ca<sup>2+</sup>-ions, and one Na<sup>+</sup>-ion. The confidence score (pLDDT) mapped on the structure of the predicted model is shown in Fig.&#160;<xref rid="MOESM1" ref-type="media">S15</xref>.</p></sec><sec id="Sec20"><title>H7N7/SC35M infection and inhibition of multicycle virus replication</title><p id="Par56">Recombinant influenza A virus H7N7/SC35M (reverse genetics system was kindly provided by J&#252;rgen Stech (Friedrich Loeffler Institute, Greifswald - Isle of Riems, Germany)). H7N7/SC35M was propagated in Madin-Darby canine kidney II (MDCKII) cells (Source: Institute of Virology, Philipps University Marburg; not authenticated as part of this study) in infection medium (Dulbecco&#8217;s Modified Eagle Medium (DMEM, Gibco, Thermo Fisher Scientific, Paisley, UK) supplemented with 0.1% bovine serum albumin (SIGMA-ALDRICH Co.), penicillin, streptomycin (Gibco, Thermo Fisher Scientific), and 2&#8201;mM <sc>L-g</sc>lutamine (Gibco, Thermo Fisher Scientific). Virus-containing cell supernatants were cleared from cell debris by low-speed centrifugation and stored as virus stocks at &#8722;80&#8201;&#176;C. For inhibition of H7N7/SC35M multicycle replication, human lung adenocarcinoma cells (A549; Source: Institute of Virology, Philipps University Marburg; not authenticated as part of this study) were grown in DMEM supplemented with 10% fetal bovine serum (FBS, Gibco, Thermo Fisher Scientific), penicillin, streptomycin and 2&#8201;mM <sc>L-g</sc>lutamine until 95&#8201;% confluence. Growth medium was removed, cells were washed with PBS def. and infected with H7N7/SC35M at a low multiplicity of infection (MOI) of 0.0001 for 1&#8201;h at 37&#8201;&#176;C, 5% CO<sub>2</sub>. Inoculum was removed, cells were washed with PBS def. and fresh medium with or without inhibitors was added. Cells were then further incubated at 37&#8201;&#176;C, 5% CO<sub>2</sub> for 72&#8201;h in total. 50&#8201;&#181;L cell supernatant was collected at different time points and stored at &#8722;20&#8201;&#176;C until plaque assay titration.</p></sec><sec id="Sec21"><title>Plaque assay titration SC35M</title><p id="Par57">MDCKII cells were cultured until 95% cell confluence was reached, growth medium was removed, and cells washed with PBS def. Cells were then inoculated with 10-fold serial dilutions of virus-containing cell supernatants in DMEM supplemented with 0.1% BSA, penicillin, streptomycin, and 2&#8201;mM L-glutamine and incubated at 37&#8201;&#176;C, 5% CO<sub>2</sub> for 1&#8201;h. Inoculum was removed and replaced with 50% v/v double-concentrated MEM (2xMEM (Gibco) supplemented with 0.6% BSA, penicillin, streptomycin, 4&#8201;mM L-glutamine, and 50% cellulose solution (Avicel, Sigma Aldrich) 2.5% w/v in double-distilled H<sub>2</sub>O) and incubated for 48&#8201;h at 37&#8201;&#176;C, 5% CO<sub>2</sub>. Overlay was removed and cells were washed three times with PBS def. Cells were then fixed with 4% w/v formaldehyde in PBS def. at 4&#8201;&#176;C for 30&#8201;min. Next, cells were stained with Giemsa&#8217;s Azur eosin methylene blue solution (Merck Millipore). Virus-infected areas were counted, and plaque-forming units per mL were calculated.</p></sec><sec id="Sec22"><title>Analyses of HA cleavage</title><p id="Par58">A549 cells were cultured in 12-well plates and grown to 95% confluence in DMEM supplemented with 10% fetal bovine serum (FBS), penicillin, streptomycin, and 2&#8201;mM <sc>L-g</sc>lutamine at 37&#8201;&#176;C, 5% CO<sub>2</sub>. Growth medium was removed, cells were washed with PBS def. and infected with H7N7/SC35M at a high MOI of 0.1 in DMEM supplemented with 0.1% BSA, penicillin, streptomycin, and 2&#8201;mM <sc>L-g</sc>lutamine for 1&#8201;h at 37&#8201;&#176;C, 5% CO<sub>2</sub>. Inoculum was removed, cells were washed with PBS def., and then treated with inhibitors at the indicated concentrations and incubated in the presence of inhibitors for 24&#8201;h at 37&#8201;&#176;C, 5% CO<sub>2</sub>. Subsequently, cells were washed with PBS def., lysed in Cell Lysis buffer (CellLytic M, Sigma-Aldrich Pty Ltd, Merck KGaA) supplemented with 0.1% v/v Protease Inhibitor-Cocktail (Protease Inhibitor-Cocktail derived from bovine lung, Sigma-Aldrich Pty Ltd, Merck KGaA), mixed with 6x reducing Laemmli buffer, and heated at 95&#8201;&#176;C for 10&#8201;min. Cell lysates were subjected to SDS-PAGE (12% polyacrylamide gel), transferred to a polyvinylidene difluoride (PVDF) membrane (GE Healthcare, Freiburg, Germany), and detected with primary antibodies (polyclonal rabbit serum against H7, diluted 1:500, Sino Biological Inc., Catalog-No.: 40104-T62 and monoclonal Anti-&#945;-Tubulin antibody produced in mouse, diluted 1:1000, SIGMA-ALDRICH Co., Catalog-No.: 40104-T62) and peroxidase-conjugated secondary anti-rabbit (diluted 1:6000, Agilent Dako, Catalog-No.: P021702-2) and anti-mouse antibodies (diluted 1:6000, Agilent Dako, Catalog-No.: P026002-2). Proteins were visualized using the ChemiDoc XRS+ system with Image Lab software (Bio-Rad).</p></sec><sec id="Sec23"><title>Stability assays in cell culture</title><p id="Par59">A549 cells were cultured in 24-well plates in DMEM supplemented with 10% fetal bovine serum (FBS), penicillin, streptomycin, and 2&#8201;mM <sc>L-g</sc>lutamine at 37&#8201;&#176;C, 5% CO<sub>2</sub> until 95% cell confluence was reached. Growth medium was removed, cells washed with PBS def., and DMEM supplemented with 0.1% BSA, penicillin, streptomycin, and 2&#8201;mM <sc>L-g</sc>lutamine was added. One micrometer of PC1/3-prodomain variants and PC1/3-prodomain-nanobody fusion proteins were added to the medium and cultivated 72&#8201;h. As negative control buffer without protein was added to the cells. Medium samples were taken at 0&#8201;h (directly after addition of the proteins), 24&#8201;h, or 72&#8201;h and stored at &#8722;20&#8201;&#176;C until enzyme activity measurement. As negative control buffer without protein was added to the cells. Activity of furin was measured at 25&#8201;&#176;C in cell culture medium diluted 1:20 in 45&#8201;mM Hepes/NaOH, pH 7.4, 135&#8201;mM NaCl, 1.8&#8201;mM CaCl2, 0.18% Triton X-100, 20&#8201;&#181;M pERTKR-AMC, and 2&#8201;nM furin using a microplate reader (Infinite 200 with i-control 2.0.10.0, Tecan). The activity of furin in presence of fresh cell culture medium was set to 100% activity and used to normalize the activities of conditioned cell culture medium. Inhibition by conditioned medium was calculated: 100%&#8212;activity [%]. All measurements were performed in triplicate (<italic toggle="yes">n</italic>&#8201;=&#8201;3). For western blot analysis 3&#8201;&#181;l of conditioned cell culture medium containing <bold>F1</bold> or <bold>F2</bold> was subjected to SDS-PAGE, transferred to a nitrocellulose membrane (GE Healthcare, Freiburg, Germany), and detected with a primary anti-nanobody antibody (rabbit anti-camelid VHH, mAb cocktail, diluted 1:2000, GenScript, Catalog-No.: A02014) and an anti-rabbit peroxidase-conjugated secondary antibody (diluted 1:40000, Cell Signaling Technology, Catalog-No.: 7074S). Proteins were visualized using the ChemiDoc XRS+ system (Bio-Rad) with Image Lab software (v 6.0.1, Bio-Rad).</p></sec><sec id="Sec24"><title>Reporting summary</title><p id="Par60">Further information on research design is available in the&#160;<xref rid="MOESM2" ref-type="media">Nature Portfolio Reporting Summary</xref> linked to this article.</p></sec></sec><sec id="Sec25" sec-type="supplementary-material"><title>Supplementary information</title><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xlink:href="41467_2025_63479_MOESM1_ESM.pdf" position="float" orientation="portrait"><caption><p>Supplementary Information</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2" position="float" orientation="portrait"><media xlink:href="41467_2025_63479_MOESM2_ESM.pdf" position="float" orientation="portrait"><caption><p>Reporting Summary</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3" position="float" orientation="portrait"><media xlink:href="41467_2025_63479_MOESM3_ESM.pdf" position="float" orientation="portrait"><caption><p>Transparent Peer Review file</p></caption></media></supplementary-material>
</p></sec><sec id="Sec26" sec-type="supplementary-material"><title>Source data</title><p>
<supplementary-material content-type="local-data" id="MOESM4" position="float" orientation="portrait"><media xlink:href="41467_2025_63479_MOESM4_ESM.zip" position="float" orientation="portrait"><caption><p>Source data</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Rupert Klaushofer, Konstantin Bloch.</p></fn></fn-group><sec><title>Supplementary information</title><p>The online version contains supplementary material available at 10.1038/s41467-025-63479-y.</p></sec><ack><title>Acknowledgements</title><p>We acknowledge the European Synchrotron Radiation Facility (ESRF) for provision of synchrotron radiation at the beamlines ID23-1 and ID23-2 as part of the Austrian BAG proposal and thank the scientific staff for assistance. Funding was provided by the Austrian Science Fund (FWF) to S.O.D. (P36648-B), The State of Hesse LOEWE Center DRUID (project D1) to E.B.-F., the Erasmus+ program of the European Union to S.M. Open access publication was supported by the Paris Lodron University of Salzburg Publication Fund.&#160;We thank Torsten Steinmetzer (Philipps University Marburg) for providing the substrates 10 and 11.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>R.K., K.B., M.S., E.B.-F., H.B., and S.O.D. designed research; R.K., K.B., L.S.E., S.M., M.S. and S.O.D. performed research; R.K., K.B., L.S.E., S.M., M.S., E.B.-F., H.B., and S.O.D. analyzed data; R.K., K.B., and S.O.D. wrote the paper. All authors reviewed and revised the paper.</p></notes><notes notes-type="peer-review"><title>Peer review</title><sec id="FPar1"><title>Peer review information</title><p id="Par61"><italic toggle="yes">Nature Communications</italic> thanks James Aramini, Iris Lindberg and the other anonymous reviewer(s) for their contribution to the peer review of this work. A peer review file is available.</p></sec></notes><notes notes-type="data-availability"><title>Data availability</title><p>Structures of <bold>M5</bold>:furin, <bold>M2</bold>:furin and <bold>M2</bold> are deposited in the protein database (PDB) under the PDB-IDs <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2210/pdb9FID/pdb">9FID</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2210/pdb9FIE/pdb">9FIE</ext-link>, and <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2210/pdb9FIC/pdb">9FIC</ext-link>. The chemical shift assignments are made publicly available at the BioMagResBank<sup><xref ref-type="bibr" rid="CR61">61</xref></sup> under the accession code <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.13018/BMR52871">52871</ext-link>. The model of the <bold>F1</bold>:furin complex predicted with Alphafold 3, all input data used, and the complete output data are available at <ext-link ext-link-type="uri" xlink:href="https://www.modelarchive.org">https://www.modelarchive.org</ext-link> under 10.5452/ma-mg3kp. PDB-IDs cited in this study: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2210/pdb1KN6/pdb">1KN6</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2210/pdb5JXG/pdb">5JXG</ext-link>. Source data are provided with this paper as a Source Data File.</p></notes><notes notes-type="data-availability"><title>Code availability</title><p>The code of the scripts used in this work are available under 10.5281/zenodo.16356790.</p></notes><notes id="FPar2" notes-type="COI-statement"><title>Competing interests</title><p id="Par62">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomas</surname><given-names>G</given-names></name></person-group><article-title>Furin at the cutting edge: from protein traffic to embryogenesis and disease</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2002</year><volume>3</volume><fpage>753</fpage><lpage>766</lpage><pub-id pub-id-type="pmid">12360192</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrm934</pub-id><pub-id pub-id-type="pmcid">PMC1964754</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Thomas, G. Furin at the cutting edge: from protein traffic to embryogenesis and disease. <italic toggle="yes">Nat. Rev. Mol. Cell Biol.</italic><bold>3</bold>, 753&#8211;766 (2002).<pub-id pub-id-type="pmid">12360192</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrm934</pub-id><pub-id pub-id-type="pmcid">PMC1964754</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Artenstein</surname><given-names>AW</given-names></name><name name-style="western"><surname>Opal</surname><given-names>SM</given-names></name></person-group><article-title>Proprotein convertases in health and disease</article-title><source>N. Engl. J. Med.</source><year>2011</year><volume>365</volume><fpage>2507</fpage><lpage>2518</lpage><pub-id pub-id-type="pmid">22204726</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMra1106700</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Artenstein, A. W. &amp; Opal, S. M. Proprotein convertases in health and disease. <italic toggle="yes">N. Engl. J. Med.</italic><bold>365</bold>, 2507&#8211;2518 (2011).<pub-id pub-id-type="pmid">22204726</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMra1106700</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seidah</surname><given-names>NG</given-names></name><name name-style="western"><surname>Prat</surname><given-names>A</given-names></name></person-group><article-title>The biology and therapeutic targeting of the proprotein convertases</article-title><source>Nat. Rev. Drug Discov.</source><year>2012</year><volume>11</volume><fpage>367</fpage><lpage>383</lpage><pub-id pub-id-type="pmid">22679642</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrd3699</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Seidah, N. G. &amp; Prat, A. The biology and therapeutic targeting of the proprotein convertases. <italic toggle="yes">Nat. Rev. Drug Discov.</italic><bold>11</bold>, 367&#8211;383 (2012).<pub-id pub-id-type="pmid">22679642</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrd3699</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Henrich</surname><given-names>S</given-names></name><etal/></person-group><article-title>The crystal structure of the proprotein processing proteinase furin explains its stringent specificity</article-title><source>Nat. Struct. Biol.</source><year>2003</year><volume>10</volume><fpage>520</fpage><lpage>526</lpage><pub-id pub-id-type="pmid">12794637</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nsb941</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Henrich, S. et al. The crystal structure of the proprotein processing proteinase furin explains its stringent specificity. <italic toggle="yes">Nat. Struct. Biol.</italic><bold>10</bold>, 520&#8211;526 (2003).<pub-id pub-id-type="pmid">12794637</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nsb941</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dahms</surname><given-names>SO</given-names></name><name name-style="western"><surname>Arciniega</surname><given-names>M</given-names></name><name name-style="western"><surname>Steinmetzer</surname><given-names>T</given-names></name><name name-style="western"><surname>Huber</surname><given-names>R</given-names></name><name name-style="western"><surname>Than</surname><given-names>ME</given-names></name></person-group><article-title>Structure of the unliganded form of the proprotein convertase furin suggests activation by a substrate-induced mechanism</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2016</year><volume>113</volume><fpage>11196</fpage><lpage>11201</lpage><pub-id pub-id-type="pmid">27647913</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1613630113</pub-id><pub-id pub-id-type="pmcid">PMC5056075</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Dahms, S. O., Arciniega, M., Steinmetzer, T., Huber, R. &amp; Than, M. E. Structure of the unliganded form of the proprotein convertase furin suggests activation by a substrate-induced mechanism. <italic toggle="yes">Proc. Natl. Acad. Sci. USA</italic><bold>113</bold>, 11196&#8211;11201 (2016).<pub-id pub-id-type="pmid">27647913</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1613630113</pub-id><pub-id pub-id-type="pmcid">PMC5056075</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>Z</given-names></name><name name-style="western"><surname>Khatib</surname><given-names>AM</given-names></name><name name-style="western"><surname>Creemers</surname><given-names>JWM</given-names></name></person-group><article-title>The proprotein convertase furin in cancer: more than an oncogene</article-title><source>Oncogene</source><year>2022</year><volume>41</volume><fpage>1252</fpage><lpage>1262</lpage><pub-id pub-id-type="pmid">34997216</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41388-021-02175-9</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">He, Z., Khatib, A. M. &amp; Creemers, J. W. M. The proprotein convertase furin in cancer: more than an oncogene. <italic toggle="yes">Oncogene</italic><bold>41</bold>, 1252&#8211;1262 (2022).<pub-id pub-id-type="pmid">34997216</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41388-021-02175-9</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klein-Szanto</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Bassi</surname><given-names>DE</given-names></name></person-group><article-title>Proprotein convertase inhibition: Paralyzing the cell&#8217;s master switches</article-title><source>Biochem. Pharm.</source><year>2017</year><volume>140</volume><fpage>8</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">28456517</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bcp.2017.04.027</pub-id><pub-id pub-id-type="pmcid">PMC5586041</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Klein-Szanto, A. J. &amp; Bassi, D. E. Proprotein convertase inhibition: Paralyzing the cell&#8217;s master switches. <italic toggle="yes">Biochem. Pharm.</italic><bold>140</bold>, 8&#8211;15 (2017).<pub-id pub-id-type="pmid">28456517</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bcp.2017.04.027</pub-id><pub-id pub-id-type="pmcid">PMC5586041</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Couture</surname><given-names>F</given-names></name><name name-style="western"><surname>Kwiatkowska</surname><given-names>A</given-names></name><name name-style="western"><surname>Dory</surname><given-names>YL</given-names></name><name name-style="western"><surname>Day</surname><given-names>R</given-names></name></person-group><article-title>Therapeutic uses of furin and its inhibitors: a patent review</article-title><source>Expert Opin. Ther. Pat.</source><year>2015</year><volume>25</volume><fpage>379</fpage><lpage>396</lpage><pub-id pub-id-type="pmid">25563687</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1517/13543776.2014.1000303</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Couture, F., Kwiatkowska, A., Dory, Y. L. &amp; Day, R. Therapeutic uses of furin and its inhibitors: a patent review. <italic toggle="yes">Expert Opin. Ther. Pat.</italic><bold>25</bold>, 379&#8211;396 (2015).<pub-id pub-id-type="pmid">25563687</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1517/13543776.2014.1000303</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Braun</surname><given-names>E</given-names></name><name name-style="western"><surname>Sauter</surname><given-names>D</given-names></name></person-group><article-title>Furin-mediated protein processing in infectious diseases and cancer</article-title><source>Clin. Transl. Immunol.</source><year>2019</year><volume>8</volume><fpage>e1073</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cti2.1073</pub-id><pub-id pub-id-type="pmcid">PMC6682551</pub-id><pub-id pub-id-type="pmid">31406574</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Braun, E. &amp; Sauter, D. Furin-mediated protein processing in infectious diseases and cancer. <italic toggle="yes">Clin. Transl. Immunol.</italic><bold>8</bold>, e1073 (2019).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cti2.1073</pub-id><pub-id pub-id-type="pmcid">PMC6682551</pub-id><pub-id pub-id-type="pmid">31406574</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stieneke-Gr&#246;ber</surname><given-names>A</given-names></name><etal/></person-group><article-title>Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease</article-title><source>EMBO J.</source><year>1992</year><volume>11</volume><fpage>2407</fpage><lpage>2414</lpage><pub-id pub-id-type="pmid">1628614</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/j.1460-2075.1992.tb05305.x</pub-id><pub-id pub-id-type="pmcid">PMC556715</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Stieneke-Gr&#246;ber, A. et al. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. <italic toggle="yes">EMBO J.</italic><bold>11</bold>, 2407&#8211;2414 (1992).<pub-id pub-id-type="pmid">1628614</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/j.1460-2075.1992.tb05305.x</pub-id><pub-id pub-id-type="pmcid">PMC556715</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heindl</surname><given-names>MR</given-names></name><name name-style="western"><surname>Bottcher-Friebertshauser</surname><given-names>E</given-names></name></person-group><article-title>The role of influenza-A virus and coronavirus viral glycoprotein cleavage in host adaptation</article-title><source>Curr. Opin. Virol.</source><year>2023</year><volume>58</volume><fpage>101303</fpage><pub-id pub-id-type="pmid">36753938</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.coviro.2023.101303</pub-id><pub-id pub-id-type="pmcid">PMC9847222</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Heindl, M. R. &amp; Bottcher-Friebertshauser, E. The role of influenza-A virus and coronavirus viral glycoprotein cleavage in host adaptation. <italic toggle="yes">Curr. Opin. Virol.</italic><bold>58</bold>, 101303 (2023).<pub-id pub-id-type="pmid">36753938</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.coviro.2023.101303</pub-id><pub-id pub-id-type="pmcid">PMC9847222</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walls</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein</article-title><source>Cell</source><year>2020</year><volume>181</volume><fpage>281</fpage><lpage>292.e286</lpage><pub-id pub-id-type="pmid">32155444</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2020.02.058</pub-id><pub-id pub-id-type="pmcid">PMC7102599</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Walls, A. C. et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. <italic toggle="yes">Cell</italic><bold>181</bold>, 281&#8211;292.e286 (2020).<pub-id pub-id-type="pmid">32155444</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2020.02.058</pub-id><pub-id pub-id-type="pmcid">PMC7102599</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Henrich</surname><given-names>S</given-names></name><name name-style="western"><surname>Lindberg</surname><given-names>I</given-names></name><name name-style="western"><surname>Bode</surname><given-names>W</given-names></name><name name-style="western"><surname>Than</surname><given-names>ME</given-names></name></person-group><article-title>Proprotein convertase models based on the crystal structures of furin and kexin: explanation of their specificity</article-title><source>J. Mol. Biol.</source><year>2005</year><volume>345</volume><fpage>211</fpage><lpage>227</lpage><pub-id pub-id-type="pmid">15571716</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jmb.2004.10.050</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Henrich, S., Lindberg, I., Bode, W. &amp; Than, M. E. Proprotein convertase models based on the crystal structures of furin and kexin: explanation of their specificity. <italic toggle="yes">J. Mol. Biol.</italic><bold>345</bold>, 211&#8211;227 (2005).<pub-id pub-id-type="pmid">15571716</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jmb.2004.10.050</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Becker</surname><given-names>GL</given-names></name><etal/></person-group><article-title>Highly potent inhibitors of proprotein convertase furin as potential drugs for treatment of infectious diseases</article-title><source>J. Biol. Chem.</source><year>2012</year><volume>287</volume><fpage>21992</fpage><lpage>22003</lpage><pub-id pub-id-type="pmid">22539349</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M111.332643</pub-id><pub-id pub-id-type="pmcid">PMC3381159</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Becker, G. L. et al. Highly potent inhibitors of proprotein convertase furin as potential drugs for treatment of infectious diseases. <italic toggle="yes">J. Biol. Chem.</italic><bold>287</bold>, 21992&#8211;22003 (2012).<pub-id pub-id-type="pmid">22539349</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M111.332643</pub-id><pub-id pub-id-type="pmcid">PMC3381159</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="other">Douglas, L. E. J., Reihill, J. A., Montgomery, B. M. &amp; Martin, S. L. Furin as a therapeutic target in cystic fibrosis airways disease. <italic toggle="yes">Eur. Respir. Rev.</italic><bold>32</bold>, 10.1183/16000617.0256-2022 (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1183/16000617.0256-2022</pub-id><pub-id pub-id-type="pmcid">PMC10155048</pub-id><pub-id pub-id-type="pmid">37137509</pub-id></mixed-citation></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Essalmani</surname><given-names>R</given-names></name><etal/></person-group><article-title>Distinctive roles of furin and TMPRSS2 in SARS-CoV-2 infectivity</article-title><source>J. Virol.</source><year>2022</year><volume>96</volume><fpage>e0012822</fpage><pub-id pub-id-type="pmid">35343766</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/jvi.00128-22</pub-id><pub-id pub-id-type="pmcid">PMC9044946</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Essalmani, R. et al. Distinctive roles of furin and TMPRSS2 in SARS-CoV-2 infectivity. <italic toggle="yes">J. Virol.</italic><bold>96</bold>, e0012822 (2022).<pub-id pub-id-type="pmid">35343766</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/jvi.00128-22</pub-id><pub-id pub-id-type="pmcid">PMC9044946</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dahms</surname><given-names>SO</given-names></name><etal/></person-group><article-title>Dichlorophenylpyridine-based molecules inhibit furin through an induced-fit mechanism</article-title><source>ACS Chem. Biol.</source><year>2022</year><volume>17</volume><fpage>816</fpage><lpage>821</lpage><pub-id pub-id-type="pmid">35377598</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acschembio.2c00103</pub-id><pub-id pub-id-type="pmcid">PMC9016704</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Dahms, S. O. et al. Dichlorophenylpyridine-based molecules inhibit furin through an induced-fit mechanism. <italic toggle="yes">ACS Chem. Biol.</italic><bold>17</bold>, 816&#8211;821 (2022).<pub-id pub-id-type="pmid">35377598</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acschembio.2c00103</pub-id><pub-id pub-id-type="pmcid">PMC9016704</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dahms</surname><given-names>SO</given-names></name><etal/></person-group><article-title>The structure of a furin-antibody complex explains non-competitive inhibition by steric exclusion of substrate conformers</article-title><source>Sci. Rep.</source><year>2016</year><volume>6</volume><fpage>34303</fpage><pub-id pub-id-type="pmid">27670069</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/srep34303</pub-id><pub-id pub-id-type="pmcid">PMC5037460</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Dahms, S. O. et al. The structure of a furin-antibody complex explains non-competitive inhibition by steric exclusion of substrate conformers. <italic toggle="yes">Sci. Rep.</italic><bold>6</bold>, 34303 (2016).<pub-id pub-id-type="pmid">27670069</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/srep34303</pub-id><pub-id pub-id-type="pmcid">PMC5037460</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Generation and characterization of non-competitive furin-inhibiting nanobodies</article-title><source>Biochem. J.</source><year>2012</year><volume>448</volume><fpage>73</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">22920187</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1042/BJ20120537</pub-id><pub-id pub-id-type="pmcid">PMC4737579</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Zhu, J. et al. Generation and characterization of non-competitive furin-inhibiting nanobodies. <italic toggle="yes">Biochem. J.</italic><bold>448</bold>, 73&#8211;82 (2012).<pub-id pub-id-type="pmid">22920187</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1042/BJ20120537</pub-id><pub-id pub-id-type="pmcid">PMC4737579</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Becker</surname><given-names>GL</given-names></name><etal/></person-group><article-title>Potent inhibitors of furin and furin-like proprotein convertases containing decarboxylated P1 arginine mimetics</article-title><source>J. Med. Chem.</source><year>2010</year><volume>53</volume><fpage>1067</fpage><lpage>1075</lpage><pub-id pub-id-type="pmid">20038105</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/jm9012455</pub-id><pub-id pub-id-type="pmcid">PMC2834293</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Becker, G. L. et al. Potent inhibitors of furin and furin-like proprotein convertases containing decarboxylated P1 arginine mimetics. <italic toggle="yes">J. Med. Chem.</italic><bold>53</bold>, 1067&#8211;1075 (2010).<pub-id pub-id-type="pmid">20038105</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/jm9012455</pub-id><pub-id pub-id-type="pmcid">PMC2834293</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Creemers</surname><given-names>JW</given-names></name><etal/></person-group><article-title>Endoproteolytic cleavage of its propeptide is a prerequisite for efficient transport of furin out of the endoplasmic reticulum</article-title><source>J. Biol. Chem.</source><year>1995</year><volume>270</volume><fpage>2695</fpage><lpage>2702</lpage><pub-id pub-id-type="pmid">7852339</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.270.6.2695</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Creemers, J. W. et al. Endoproteolytic cleavage of its propeptide is a prerequisite for efficient transport of furin out of the endoplasmic reticulum. <italic toggle="yes">J. Biol. Chem.</italic><bold>270</bold>, 2695&#8211;2702 (1995).<pub-id pub-id-type="pmid">7852339</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.270.6.2695</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Molloy</surname><given-names>SS</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>L</given-names></name><name name-style="western"><surname>VanSlyke</surname><given-names>JK</given-names></name><name name-style="western"><surname>Stenberg</surname><given-names>PE</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>G</given-names></name></person-group><article-title>Intracellular trafficking and activation of the furin proprotein convertase: localization to the TGN and recycling from the cell surface</article-title><source>EMBO J.</source><year>1994</year><volume>13</volume><fpage>18</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">7508380</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/j.1460-2075.1994.tb06231.x</pub-id><pub-id pub-id-type="pmcid">PMC394775</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Molloy, S. S., Thomas, L., VanSlyke, J. K., Stenberg, P. E. &amp; Thomas, G. Intracellular trafficking and activation of the furin proprotein convertase: localization to the TGN and recycling from the cell surface. <italic toggle="yes">EMBO J.</italic><bold>13</bold>, 18&#8211;33 (1994).<pub-id pub-id-type="pmid">7508380</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/j.1460-2075.1994.tb06231.x</pub-id><pub-id pub-id-type="pmcid">PMC394775</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>ED</given-names></name><name name-style="western"><surname>VanSlyke</surname><given-names>JK</given-names></name><name name-style="western"><surname>Thulin</surname><given-names>CD</given-names></name><name name-style="western"><surname>Jean</surname><given-names>F</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>G</given-names></name></person-group><article-title>Activation of the furin endoprotease is a multiple-step process: requirements for acidification and internal propeptide cleavage</article-title><source>EMBO J.</source><year>1997</year><volume>16</volume><fpage>1508</fpage><lpage>1518</lpage><pub-id pub-id-type="pmid">9130696</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/emboj/16.7.1508</pub-id><pub-id pub-id-type="pmcid">PMC1169755</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Anderson, E. D., VanSlyke, J. K., Thulin, C. D., Jean, F. &amp; Thomas, G. Activation of the furin endoprotease is a multiple-step process: requirements for acidification and internal propeptide cleavage. <italic toggle="yes">EMBO J.</italic><bold>16</bold>, 1508&#8211;1518 (1997).<pub-id pub-id-type="pmid">9130696</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/emboj/16.7.1508</pub-id><pub-id pub-id-type="pmcid">PMC1169755</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feliciangeli</surname><given-names>SF</given-names></name><etal/></person-group><article-title>Identification of a pH sensor in the furin propeptide that regulates enzyme activation</article-title><source>J. Biol. Chem.</source><year>2006</year><volume>281</volume><fpage>16108</fpage><lpage>16116</lpage><pub-id pub-id-type="pmid">16601116</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M600760200</pub-id><pub-id pub-id-type="pmcid">PMC4293020</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Feliciangeli, S. F. et al. Identification of a pH sensor in the furin propeptide that regulates enzyme activation. <italic toggle="yes">J. Biol. Chem.</italic><bold>281</bold>, 16108&#8211;16116 (2006).<pub-id pub-id-type="pmid">16601116</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M600760200</pub-id><pub-id pub-id-type="pmcid">PMC4293020</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elferich</surname><given-names>J</given-names></name><name name-style="western"><surname>Williamson</surname><given-names>DM</given-names></name><name name-style="western"><surname>Krishnamoorthy</surname><given-names>B</given-names></name><name name-style="western"><surname>Shinde</surname><given-names>U</given-names></name></person-group><article-title>Propeptides of eukaryotic proteases encode histidines to exploit organelle pH for regulation</article-title><source>FASEB J.</source><year>2013</year><volume>27</volume><fpage>2939</fpage><lpage>2945</lpage><pub-id pub-id-type="pmid">23585398</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1096/fj.12-226886</pub-id><pub-id pub-id-type="pmcid">PMC3714588</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Elferich, J., Williamson, D. M., Krishnamoorthy, B. &amp; Shinde, U. Propeptides of eukaryotic proteases encode histidines to exploit organelle pH for regulation. <italic toggle="yes">FASEB J.</italic><bold>27</bold>, 2939&#8211;2945 (2013).<pub-id pub-id-type="pmid">23585398</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1096/fj.12-226886</pub-id><pub-id pub-id-type="pmcid">PMC3714588</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Williamson</surname><given-names>DM</given-names></name><name name-style="western"><surname>Elferich</surname><given-names>J</given-names></name><name name-style="western"><surname>Ramakrishnan</surname><given-names>P</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>G</given-names></name><name name-style="western"><surname>Shinde</surname><given-names>U</given-names></name></person-group><article-title>The mechanism by which a propeptide-encoded pH sensor regulates spatiotemporal activation of furin</article-title><source>J. Biol. Chem.</source><year>2013</year><volume>288</volume><fpage>19154</fpage><lpage>19165</lpage><pub-id pub-id-type="pmid">23653353</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M112.442681</pub-id><pub-id pub-id-type="pmcid">PMC3696687</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Williamson, D. M., Elferich, J., Ramakrishnan, P., Thomas, G. &amp; Shinde, U. The mechanism by which a propeptide-encoded pH sensor regulates spatiotemporal activation of furin. <italic toggle="yes">J. Biol. Chem.</italic><bold>288</bold>, 19154&#8211;19165 (2013).<pub-id pub-id-type="pmid">23653353</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M112.442681</pub-id><pub-id pub-id-type="pmcid">PMC3696687</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Williamson</surname><given-names>DM</given-names></name><name name-style="western"><surname>Elferich</surname><given-names>J</given-names></name><name name-style="western"><surname>Shinde</surname><given-names>U</given-names></name></person-group><article-title>Mechanism of fine-tuning pH sensors in proprotein convertases: identification of a ph-sensing histidine pair in the propeptide of proprotein convertase 1/3</article-title><source>J. Biol. Chem.</source><year>2015</year><volume>290</volume><fpage>23214</fpage><lpage>23225</lpage><pub-id pub-id-type="pmid">26229104</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M115.665430</pub-id><pub-id pub-id-type="pmcid">PMC4645620</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Williamson, D. M., Elferich, J. &amp; Shinde, U. Mechanism of fine-tuning pH sensors in proprotein convertases: identification of a ph-sensing histidine pair in the propeptide of proprotein convertase 1/3. <italic toggle="yes">J. Biol. Chem.</italic><bold>290</bold>, 23214&#8211;23225 (2015).<pub-id pub-id-type="pmid">26229104</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M115.665430</pub-id><pub-id pub-id-type="pmcid">PMC4645620</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seidah</surname><given-names>NG</given-names></name><etal/></person-group><article-title>cDNA structure, tissue distribution, and chromosomal localization of rat PC7, a novel mammalian proprotein convertase closest to yeast kexin-like proteinases</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1996</year><volume>93</volume><fpage>3388</fpage><lpage>3393</lpage><pub-id pub-id-type="pmid">8622945</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.93.8.3388</pub-id><pub-id pub-id-type="pmcid">PMC39618</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Seidah, N. G. et al. cDNA structure, tissue distribution, and chromosomal localization of rat PC7, a novel mammalian proprotein convertase closest to yeast kexin-like proteinases. <italic toggle="yes">Proc. Natl. Acad. Sci. USA</italic><bold>93</bold>, 3388&#8211;3393 (1996).<pub-id pub-id-type="pmid">8622945</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.93.8.3388</pub-id><pub-id pub-id-type="pmcid">PMC39618</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rousselet</surname><given-names>E</given-names></name><name name-style="western"><surname>Benjannet</surname><given-names>S</given-names></name><name name-style="western"><surname>Hamelin</surname><given-names>J</given-names></name><name name-style="western"><surname>Canuel</surname><given-names>M</given-names></name><name name-style="western"><surname>Seidah</surname><given-names>NG</given-names></name></person-group><article-title>The proprotein convertase PC7: unique zymogen activation and trafficking pathways</article-title><source>J. Biol. Chem.</source><year>2011</year><volume>286</volume><fpage>2728</fpage><lpage>2738</lpage><pub-id pub-id-type="pmid">21075846</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M110.192344</pub-id><pub-id pub-id-type="pmcid">PMC3024769</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Rousselet, E., Benjannet, S., Hamelin, J., Canuel, M. &amp; Seidah, N. G. The proprotein convertase PC7: unique zymogen activation and trafficking pathways. <italic toggle="yes">J. Biol. Chem.</italic><bold>286</bold>, 2728&#8211;2738 (2011).<pub-id pub-id-type="pmid">21075846</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M110.192344</pub-id><pub-id pub-id-type="pmcid">PMC3024769</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Levesque</surname><given-names>C</given-names></name><etal/></person-group><article-title>The Multi-Leu peptide inhibitor discriminates between PACE4 and furin and exhibits antiproliferative effects on prostate cancer cells</article-title><source>J. Med. Chem.</source><year>2012</year><volume>55</volume><fpage>10501</fpage><lpage>10511</lpage><pub-id pub-id-type="pmid">23126600</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/jm3011178</pub-id><pub-id pub-id-type="pmcid">PMC3523546</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Levesque, C. et al. The Multi-Leu peptide inhibitor discriminates between PACE4 and furin and exhibits antiproliferative effects on prostate cancer cells. <italic toggle="yes">J. Med. Chem.</italic><bold>55</bold>, 10501&#8211;10511 (2012).<pub-id pub-id-type="pmid">23126600</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/jm3011178</pub-id><pub-id pub-id-type="pmcid">PMC3523546</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rabah</surname><given-names>N</given-names></name><name name-style="western"><surname>Gauthier</surname><given-names>D</given-names></name><name name-style="western"><surname>Wilkes</surname><given-names>BC</given-names></name><name name-style="western"><surname>Gauthier</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Lazure</surname><given-names>C</given-names></name></person-group><article-title>Single amino acid substitution in the PC1/3 propeptide can induce significant modifications of its inhibitory profile toward its cognate enzyme</article-title><source>J. Biol. Chem.</source><year>2006</year><volume>281</volume><fpage>7556</fpage><lpage>7567</lpage><pub-id pub-id-type="pmid">16407210</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M510607200</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Rabah, N., Gauthier, D., Wilkes, B. C., Gauthier, D. J. &amp; Lazure, C. Single amino acid substitution in the PC1/3 propeptide can induce significant modifications of its inhibitory profile toward its cognate enzyme. <italic toggle="yes">J. Biol. Chem.</italic><bold>281</bold>, 7556&#8211;7567 (2006).<pub-id pub-id-type="pmid">16407210</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M510607200</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dahms</surname><given-names>SO</given-names></name><etal/></person-group><article-title>X-ray structures of human furin in complex with competitive inhibitors</article-title><source>ACS Chem. Biol.</source><year>2014</year><volume>9</volume><fpage>1113</fpage><lpage>1118</lpage><pub-id pub-id-type="pmid">24666235</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/cb500087x</pub-id><pub-id pub-id-type="pmcid">PMC4026159</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Dahms, S. O. et al. X-ray structures of human furin in complex with competitive inhibitors. <italic toggle="yes">ACS Chem. Biol.</italic><bold>9</bold>, 1113&#8211;1118 (2014).<pub-id pub-id-type="pmid">24666235</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/cb500087x</pub-id><pub-id pub-id-type="pmcid">PMC4026159</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Platzer</surname><given-names>G</given-names></name><name name-style="western"><surname>Okon</surname><given-names>M</given-names></name><name name-style="western"><surname>McIntosh</surname><given-names>LP</given-names></name></person-group><article-title>pH-dependent random coil (1)H, (13)C, and (15)N chemical shifts of the ionizable amino acids: a guide for protein pK a measurements</article-title><source>J. Biomol. NMR</source><year>2014</year><volume>60</volume><fpage>109</fpage><lpage>129</lpage><pub-id pub-id-type="pmid">25239571</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10858-014-9862-y</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Platzer, G., Okon, M. &amp; McIntosh, L. P. pH-dependent random coil (1)H, (13)C, and (15)N chemical shifts of the ionizable amino acids: a guide for protein pK a measurements. <italic toggle="yes">J. Biomol. NMR</italic><bold>60</bold>, 109&#8211;129 (2014).<pub-id pub-id-type="pmid">25239571</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10858-014-9862-y</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schubert</surname><given-names>M</given-names></name><etal/></person-group><article-title>Probing electrostatic interactions along the reaction pathway of a glycoside hydrolase: histidine characterization by NMR spectroscopy</article-title><source>Biochemistry</source><year>2007</year><volume>46</volume><fpage>7383</fpage><lpage>7395</lpage><pub-id pub-id-type="pmid">17547373</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/bi700249m</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Schubert, M. et al. Probing electrostatic interactions along the reaction pathway of a glycoside hydrolase: histidine characterization by NMR spectroscopy. <italic toggle="yes">Biochemistry</italic><bold>46</bold>, 7383&#8211;7395 (2007).<pub-id pub-id-type="pmid">17547373</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/bi700249m</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hardes</surname><given-names>K</given-names></name><etal/></person-group><article-title>Novel furin inhibitors with potent anti-infectious activity</article-title><source>ChemMedChem</source><year>2015</year><volume>10</volume><fpage>1218</fpage><lpage>1231</lpage><pub-id pub-id-type="pmid">25974265</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cmdc.201500103</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Hardes, K. et al. Novel furin inhibitors with potent anti-infectious activity. <italic toggle="yes">ChemMedChem</italic><bold>10</bold>, 1218&#8211;1231 (2015).<pub-id pub-id-type="pmid">25974265</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cmdc.201500103</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paroutis</surname><given-names>P</given-names></name><name name-style="western"><surname>Touret</surname><given-names>N</given-names></name><name name-style="western"><surname>Grinstein</surname><given-names>S</given-names></name></person-group><article-title>The pH of the secretory pathway: measurement, determinants, and regulation</article-title><source>Physiology</source><year>2004</year><volume>19</volume><fpage>207</fpage><lpage>215</lpage><pub-id pub-id-type="pmid">15304635</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/physiol.00005.2004</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Paroutis, P., Touret, N. &amp; Grinstein, S. The pH of the secretory pathway: measurement, determinants, and regulation. <italic toggle="yes">Physiology</italic><bold>19</bold>, 207&#8211;215 (2004).<pub-id pub-id-type="pmid">15304635</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/physiol.00005.2004</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bradbury</surname><given-names>AR</given-names></name><name name-style="western"><surname>Sidhu</surname><given-names>S</given-names></name><name name-style="western"><surname>Dubel</surname><given-names>S</given-names></name><name name-style="western"><surname>McCafferty</surname><given-names>J</given-names></name></person-group><article-title>Beyond natural antibodies: the power of in vitro display technologies</article-title><source>Nat. Biotechnol.</source><year>2011</year><volume>29</volume><fpage>245</fpage><lpage>254</lpage><pub-id pub-id-type="pmid">21390033</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nbt.1791</pub-id><pub-id pub-id-type="pmcid">PMC3057417</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Bradbury, A. R., Sidhu, S., Dubel, S. &amp; McCafferty, J. Beyond natural antibodies: the power of in vitro display technologies. <italic toggle="yes">Nat. Biotechnol.</italic><bold>29</bold>, 245&#8211;254 (2011).<pub-id pub-id-type="pmid">21390033</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nbt.1791</pub-id><pub-id pub-id-type="pmcid">PMC3057417</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Turk</surname><given-names>V</given-names></name><etal/></person-group><article-title>Cysteine cathepsins: from structure, function and regulation to new frontiers</article-title><source>Biochim. Biophys. Acta</source><year>2012</year><volume>1824</volume><fpage>68</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">22024571</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbapap.2011.10.002</pub-id><pub-id pub-id-type="pmcid">PMC7105208</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Turk, V. et al. Cysteine cathepsins: from structure, function and regulation to new frontiers. <italic toggle="yes">Biochim. Biophys. Acta</italic><bold>1824</bold>, 68&#8211;88 (2012).<pub-id pub-id-type="pmid">22024571</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbapap.2011.10.002</pub-id><pub-id pub-id-type="pmcid">PMC7105208</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tusar</surname><given-names>L</given-names></name><etal/></person-group><article-title>Proteomic data and structure analysis combined reveal interplay of structural rigidity and flexibility on selectivity of cysteine cathepsins</article-title><source>Commun. Biol.</source><year>2023</year><volume>6</volume><fpage>450</fpage><pub-id pub-id-type="pmid">37095140</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s42003-023-04772-8</pub-id><pub-id pub-id-type="pmcid">PMC10124925</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Tusar, L. et al. Proteomic data and structure analysis combined reveal interplay of structural rigidity and flexibility on selectivity of cysteine cathepsins. <italic toggle="yes">Commun. Biol.</italic><bold>6</bold>, 450 (2023).<pub-id pub-id-type="pmid">37095140</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s42003-023-04772-8</pub-id><pub-id pub-id-type="pmcid">PMC10124925</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dall</surname><given-names>E</given-names></name><name name-style="western"><surname>Brandstetter</surname><given-names>H</given-names></name></person-group><article-title>Structure and function of legumain in health and disease</article-title><source>Biochimie</source><year>2016</year><volume>122</volume><fpage>126</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">26403494</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biochi.2015.09.022</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Dall, E. &amp; Brandstetter, H. Structure and function of legumain in health and disease. <italic toggle="yes">Biochimie</italic><bold>122</bold>, 126&#8211;150 (2016).<pub-id pub-id-type="pmid">26403494</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biochi.2015.09.022</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luczo</surname><given-names>JM</given-names></name><name name-style="western"><surname>Stambas</surname><given-names>J</given-names></name><name name-style="western"><surname>Durr</surname><given-names>PA</given-names></name><name name-style="western"><surname>Michalski</surname><given-names>WP</given-names></name><name name-style="western"><surname>Bingham</surname><given-names>J</given-names></name></person-group><article-title>Molecular pathogenesis of H5 highly pathogenic avian influenza: the role of the haemagglutinin cleavage site motif</article-title><source>Rev. Med. Virol.</source><year>2015</year><volume>25</volume><fpage>406</fpage><lpage>430</lpage><pub-id pub-id-type="pmid">26467906</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/rmv.1846</pub-id><pub-id pub-id-type="pmcid">PMC5057330</pub-id></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Luczo, J. M., Stambas, J., Durr, P. A., Michalski, W. P. &amp; Bingham, J. Molecular pathogenesis of H5 highly pathogenic avian influenza: the role of the haemagglutinin cleavage site motif. <italic toggle="yes">Rev. Med. Virol.</italic><bold>25</bold>, 406&#8211;430 (2015).<pub-id pub-id-type="pmid">26467906</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/rmv.1846</pub-id><pub-id pub-id-type="pmcid">PMC5057330</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><mixed-citation publication-type="other">Dahms, S. O., Haider, T., Klebe, G., Steinmetzer, T. &amp; Brandstetter, H. OFF-state-specific inhibition of the proprotein convertase furin. <italic toggle="yes">ACS Chem. Biol.</italic>10.1021/acschembio.1c00411 (2021).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acschembio.1c00411</pub-id><pub-id pub-id-type="pmcid">PMC8453481</pub-id><pub-id pub-id-type="pmid">34415722</pub-id></mixed-citation></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuester</surname><given-names>M</given-names></name><etal/></person-group><article-title>Purification of the proprotein convertase furin by affinity chromatography based on PC-specific inhibitors</article-title><source>Biol. Chem.</source><year>2011</year><volume>392</volume><fpage>973</fpage><lpage>981</lpage><pub-id pub-id-type="pmid">21875402</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1515/BC.2011.100</pub-id><pub-id pub-id-type="pmcid">PMC3791315</pub-id></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Kuester, M. et al. Purification of the proprotein convertase furin by affinity chromatography based on PC-specific inhibitors. <italic toggle="yes">Biol. Chem.</italic><bold>392</bold>, 973&#8211;981 (2011).<pub-id pub-id-type="pmid">21875402</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1515/BC.2011.100</pub-id><pub-id pub-id-type="pmcid">PMC3791315</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lam van</surname><given-names>TV</given-names></name><etal/></person-group><article-title>Design, synthesis, and characterization of novel fluorogenic substrates of the proprotein convertases furin, PC1/3, PC2, PC5/6, and PC7</article-title><source>Anal. Biochem.</source><year>2022</year><volume>655</volume><fpage>114836</fpage><pub-id pub-id-type="pmid">35964735</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ab.2022.114836</pub-id></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Lam van, T. V. et al. Design, synthesis, and characterization of novel fluorogenic substrates of the proprotein convertases furin, PC1/3, PC2, PC5/6, and PC7. <italic toggle="yes">Anal. Biochem.</italic><bold>655</bold>, 114836 (2022).<pub-id pub-id-type="pmid">35964735</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ab.2022.114836</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nurizzo</surname><given-names>D</given-names></name><etal/></person-group><article-title>The ID23-1 structural biology beamline at the ESRF</article-title><source>J. Synchrotron Radiat.</source><year>2006</year><volume>13</volume><fpage>227</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">16645249</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1107/S0909049506004341</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Nurizzo, D. et al. The ID23-1 structural biology beamline at the ESRF. <italic toggle="yes">J. Synchrotron Radiat.</italic><bold>13</bold>, 227&#8211;238 (2006).<pub-id pub-id-type="pmid">16645249</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1107/S0909049506004341</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kabsch</surname><given-names>W</given-names></name></person-group><article-title>Xds</article-title><source>Acta Crystallogr. D. Biol. Crystallogr.</source><year>2010</year><volume>66</volume><fpage>125</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">20124692</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1107/S0907444909047337</pub-id><pub-id pub-id-type="pmcid">PMC2815665</pub-id></element-citation><mixed-citation id="mc-CR46" publication-type="journal">Kabsch, W. Xds. <italic toggle="yes">Acta Crystallogr. D. Biol. Crystallogr.</italic><bold>66</bold>, 125&#8211;132 (2010).<pub-id pub-id-type="pmid">20124692</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1107/S0907444909047337</pub-id><pub-id pub-id-type="pmcid">PMC2815665</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krug</surname><given-names>M</given-names></name><name name-style="western"><surname>Weiss</surname><given-names>MS</given-names></name><name name-style="western"><surname>Heinemann</surname><given-names>U</given-names></name><name name-style="western"><surname>Mueller</surname><given-names>U</given-names></name></person-group><article-title>XDSAPP: a graphical user interface for the convenient processing of diffraction data using XDS</article-title><source>J. Appl. Cryst.</source><year>2012</year><volume>45</volume><fpage>568</fpage><lpage>572</lpage></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Krug, M., Weiss, M. S., Heinemann, U. &amp; Mueller, U. XDSAPP: a graphical user interface for the convenient processing of diffraction data using XDS. <italic toggle="yes">J. Appl. Cryst.</italic><bold>45</bold>, 568&#8211;572 (2012).</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Winn</surname><given-names>MD</given-names></name><etal/></person-group><article-title>Overview of the CCP4 suite and current developments</article-title><source>Acta Crystallogr. D. Biol. Crystallogr.</source><year>2011</year><volume>67</volume><fpage>235</fpage><lpage>242</lpage><pub-id pub-id-type="pmid">21460441</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1107/S0907444910045749</pub-id><pub-id pub-id-type="pmcid">PMC3069738</pub-id></element-citation><mixed-citation id="mc-CR48" publication-type="journal">Winn, M. D. et al. Overview of the CCP4 suite and current developments. <italic toggle="yes">Acta Crystallogr. D. Biol. Crystallogr.</italic><bold>67</bold>, 235&#8211;242 (2011).<pub-id pub-id-type="pmid">21460441</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1107/S0907444910045749</pub-id><pub-id pub-id-type="pmcid">PMC3069738</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><mixed-citation publication-type="other">Dahms, S. O. (Zenodo, Zenodo, 2025).</mixed-citation></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nanao</surname><given-names>M</given-names></name><etal/></person-group><article-title>ID23-2: an automated and high-performance microfocus beamline for macromolecular crystallography at the ESRF</article-title><source>J. Synchrotron Radiat.</source><year>2022</year><volume>29</volume><fpage>581</fpage><lpage>590</lpage><pub-id pub-id-type="pmid">35254323</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1107/S1600577522000984</pub-id><pub-id pub-id-type="pmcid">PMC8900849</pub-id></element-citation><mixed-citation id="mc-CR50" publication-type="journal">Nanao, M. et al. ID23-2: an automated and high-performance microfocus beamline for macromolecular crystallography at the ESRF. <italic toggle="yes">J. Synchrotron Radiat.</italic><bold>29</bold>, 581&#8211;590 (2022).<pub-id pub-id-type="pmid">35254323</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1107/S1600577522000984</pub-id><pub-id pub-id-type="pmcid">PMC8900849</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tunyasuvunakool</surname><given-names>K</given-names></name><etal/></person-group><article-title>Highly accurate protein structure prediction for the human proteome</article-title><source>Nature</source><year>2021</year><volume>596</volume><fpage>590</fpage><lpage>596</lpage><pub-id pub-id-type="pmid">34293799</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-021-03828-1</pub-id><pub-id pub-id-type="pmcid">PMC8387240</pub-id></element-citation><mixed-citation id="mc-CR51" publication-type="journal">Tunyasuvunakool, K. et al. Highly accurate protein structure prediction for the human proteome. <italic toggle="yes">Nature</italic><bold>596</bold>, 590&#8211;596 (2021).<pub-id pub-id-type="pmid">34293799</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-021-03828-1</pub-id><pub-id pub-id-type="pmcid">PMC8387240</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jumper</surname><given-names>J</given-names></name><etal/></person-group><article-title>Highly accurate protein structure prediction with AlphaFold</article-title><source>Nature</source><year>2021</year><pub-id pub-id-type="pmid">34265844</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-021-03819-2</pub-id><pub-id pub-id-type="pmcid">PMC8371605</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. <italic toggle="yes">Nature</italic>10.1038/s41586-021-03819-2 (2021).<pub-id pub-id-type="pmid">34265844</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-021-03819-2</pub-id><pub-id pub-id-type="pmcid">PMC8371605</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McCoy</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Phaser crystallographic software</article-title><source>J. Appl Crystallogr</source><year>2007</year><volume>40</volume><fpage>658</fpage><lpage>674</lpage><pub-id pub-id-type="pmid">19461840</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1107/S0021889807021206</pub-id><pub-id pub-id-type="pmcid">PMC2483472</pub-id></element-citation><mixed-citation id="mc-CR53" publication-type="journal">McCoy, A. J. et al. Phaser crystallographic software. <italic toggle="yes">J. Appl Crystallogr</italic><bold>40</bold>, 658&#8211;674 (2007).<pub-id pub-id-type="pmid">19461840</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1107/S0021889807021206</pub-id><pub-id pub-id-type="pmcid">PMC2483472</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tangrea</surname><given-names>MA</given-names></name><name name-style="western"><surname>Bryan</surname><given-names>PN</given-names></name><name name-style="western"><surname>Sari</surname><given-names>N</given-names></name><name name-style="western"><surname>Orban</surname><given-names>J</given-names></name></person-group><article-title>Solution structure of the pro-hormone convertase 1 pro-domain from Mus musculus</article-title><source>J. Mol. Biol.</source><year>2002</year><volume>320</volume><fpage>801</fpage><lpage>812</lpage><pub-id pub-id-type="pmid">12095256</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0022-2836(02)00543-0</pub-id></element-citation><mixed-citation id="mc-CR54" publication-type="journal">Tangrea, M. A., Bryan, P. N., Sari, N. &amp; Orban, J. Solution structure of the pro-hormone convertase 1 pro-domain from Mus musculus. <italic toggle="yes">J. Mol. Biol.</italic><bold>320</bold>, 801&#8211;812 (2002).<pub-id pub-id-type="pmid">12095256</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0022-2836(02)00543-0</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Emsley</surname><given-names>P</given-names></name><name name-style="western"><surname>Lohkamp</surname><given-names>B</given-names></name><name name-style="western"><surname>Scott</surname><given-names>WG</given-names></name><name name-style="western"><surname>Cowtan</surname><given-names>K</given-names></name></person-group><article-title>Features and development of Coot</article-title><source>Acta Crystallogr. D. Biol. Crystallogr.</source><year>2010</year><volume>66</volume><fpage>486</fpage><lpage>501</lpage><pub-id pub-id-type="pmid">20383002</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1107/S0907444910007493</pub-id><pub-id pub-id-type="pmcid">PMC2852313</pub-id></element-citation><mixed-citation id="mc-CR55" publication-type="journal">Emsley, P., Lohkamp, B., Scott, W. G. &amp; Cowtan, K. Features and development of Coot. <italic toggle="yes">Acta Crystallogr. D. Biol. Crystallogr.</italic><bold>66</bold>, 486&#8211;501 (2010).<pub-id pub-id-type="pmid">20383002</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1107/S0907444910007493</pub-id><pub-id pub-id-type="pmcid">PMC2852313</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adams</surname><given-names>PD</given-names></name><etal/></person-group><article-title>PHENIX: a comprehensive Python-based system for macromolecular structure solution</article-title><source>Acta Crystallogr. D. Biol. Crystallogr.</source><year>2010</year><volume>66</volume><fpage>213</fpage><lpage>221</lpage><pub-id pub-id-type="pmid">20124702</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1107/S0907444909052925</pub-id><pub-id pub-id-type="pmcid">PMC2815670</pub-id></element-citation><mixed-citation id="mc-CR56" publication-type="journal">Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. <italic toggle="yes">Acta Crystallogr. D. Biol. Crystallogr.</italic><bold>66</bold>, 213&#8211;221 (2010).<pub-id pub-id-type="pmid">20124702</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1107/S0907444909052925</pub-id><pub-id pub-id-type="pmcid">PMC2815670</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sattler</surname><given-names>M</given-names></name><name name-style="western"><surname>Schleucher</surname><given-names>J</given-names></name><name name-style="western"><surname>Griesinger</surname><given-names>C</given-names></name></person-group><article-title>Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solution employing pulsed field gradients</article-title><source>Prog. Nucl. Magn. Reson. Spectrosc.</source><year>1999</year><volume>34</volume><fpage>93</fpage><lpage>158</lpage></element-citation><mixed-citation id="mc-CR57" publication-type="journal">Sattler, M., Schleucher, J. &amp; Griesinger, C. Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solution employing pulsed field gradients. <italic toggle="yes">Prog. Nucl. Magn. Reson. Spectrosc.</italic><bold>34</bold>, 93&#8211;158 (1999).</mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Farrow</surname><given-names>NA</given-names></name><etal/></person-group><article-title>Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation</article-title><source>Biochemistry</source><year>1994</year><volume>33</volume><fpage>5984</fpage><lpage>6003</lpage><pub-id pub-id-type="pmid">7514039</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/bi00185a040</pub-id></element-citation><mixed-citation id="mc-CR58" publication-type="journal">Farrow, N. A. et al. Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation. <italic toggle="yes">Biochemistry</italic><bold>33</bold>, 5984&#8211;6003 (1994).<pub-id pub-id-type="pmid">7514039</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/bi00185a040</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pelton</surname><given-names>JG</given-names></name><name name-style="western"><surname>Torchia</surname><given-names>DA</given-names></name><name name-style="western"><surname>Meadow</surname><given-names>ND</given-names></name><name name-style="western"><surname>Roseman</surname><given-names>S</given-names></name></person-group><article-title>Tautomeric states of the active-site histidines of phosphorylated and unphosphorylated IIIGlc, a signal-transducing protein from Escherichia coli, using two-dimensional heteronuclear NMR techniques</article-title><source>Protein Sci.</source><year>1993</year><volume>2</volume><fpage>543</fpage><lpage>558</lpage><pub-id pub-id-type="pmid">8518729</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/pro.5560020406</pub-id><pub-id pub-id-type="pmcid">PMC2142369</pub-id></element-citation><mixed-citation id="mc-CR59" publication-type="journal">Pelton, J. G., Torchia, D. A., Meadow, N. D. &amp; Roseman, S. Tautomeric states of the active-site histidines of phosphorylated and unphosphorylated IIIGlc, a signal-transducing protein from Escherichia coli, using two-dimensional heteronuclear NMR techniques. <italic toggle="yes">Protein Sci.</italic><bold>2</bold>, 543&#8211;558 (1993).<pub-id pub-id-type="pmid">8518729</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/pro.5560020406</pub-id><pub-id pub-id-type="pmcid">PMC2142369</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abramson</surname><given-names>J</given-names></name><etal/></person-group><article-title>Accurate structure prediction of biomolecular interactions with AlphaFold 3</article-title><source>Nature</source><year>2024</year><volume>630</volume><fpage>493</fpage><lpage>500</lpage><pub-id pub-id-type="pmid">38718835</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-024-07487-w</pub-id><pub-id pub-id-type="pmcid">PMC11168924</pub-id></element-citation><mixed-citation id="mc-CR60" publication-type="journal">Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. <italic toggle="yes">Nature</italic><bold>630</bold>, 493&#8211;500 (2024).<pub-id pub-id-type="pmid">38718835</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-024-07487-w</pub-id><pub-id pub-id-type="pmcid">PMC11168924</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ulrich</surname><given-names>EL</given-names></name><etal/></person-group><article-title>BioMagResBank</article-title><source>Nucleic Acids Res.</source><year>2008</year><volume>36</volume><fpage>D402</fpage><lpage>D408</lpage><pub-id pub-id-type="pmid">17984079</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkm957</pub-id><pub-id pub-id-type="pmcid">PMC2238925</pub-id></element-citation><mixed-citation id="mc-CR61" publication-type="journal">Ulrich, E. L. et al. BioMagResBank. <italic toggle="yes">Nucleic Acids Res.</italic><bold>36</bold>, D402&#8211;D408 (2008).<pub-id pub-id-type="pmid">17984079</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkm957</pub-id><pub-id pub-id-type="pmcid">PMC2238925</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>